WO1993008167A1 - Novel heterocyclic derivative and agrohorticultural bactericide containing same - Google Patents
Novel heterocyclic derivative and agrohorticultural bactericide containing same Download PDFInfo
- Publication number
- WO1993008167A1 WO1993008167A1 PCT/JP1992/001384 JP9201384W WO9308167A1 WO 1993008167 A1 WO1993008167 A1 WO 1993008167A1 JP 9201384 W JP9201384 W JP 9201384W WO 9308167 A1 WO9308167 A1 WO 9308167A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- substituted
- phenyl
- optionally substituted
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Definitions
- the present invention relates to a novel heterocyclic derivative and a fungicide for agricultural and horticultural use.
- An object of the present invention is to provide a novel compound which can be advantageously synthesized industrially and which can be used as a fungicide for agricultural and horticultural use which is effective and secure and can be used safely.
- the present invention has the general formula (I)
- m is an integer of 1 to 4
- R 1 is the same or different and is a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower haloalkoxy group, a lower alkylthio group, a lower haloalkyl group, a lower alkoxycarbonyl group, a nitro group, a mono- or di-optionally substituted force be Rubamoiru group or a halogen atom lower alkyl
- Nr 3 is a lower alkyl group, may be substituted A phenyl group, a lower alkoxy group, a lower alkylamino group, a hydroxy group, a phenylamino group and a lower alkoxycarbonylamino group which may be substituted.
- R 4 represents a hydrogen atom or a lower alkoxycarbonyl group.
- R 2 represents a hydrogen atom
- S (0) Strukturr 5 (r 5 is a lower alkyl group which may be substituted, n represents 0, 1 or 2), a lower alkoxy group, a lower alkylsulfonylamino group, or a substituted
- R 3 represents a hydrogen atom, a phenylsulfonylamino group, a cyano group, a halogen atom, a hydroxy group, a morpholino group, or an amino group optionally substituted with phenylalkyl or lower alkyl which may be substituted;
- r 3 represents a phenyl group which may be substituted or a phenylamino group which may be substituted
- substituents include a halogen atom, an alkyl group, an alkoxy group, an alkylamino group, an alkylthio group, a cyano group, and a nitro group.
- R 5 may be substituted, and when it represents a lower alkyl group, examples of the substituent include a halogen atom, an alkoxy group, an alkylthio group, an alkylamino group, a phenyl group, an alkoxycarbonyl group, and a substituent. Power such as canolebamoinole group.
- examples of the substituent include a halogen atom, an alkyl group, an alkoxy group, an alkylamino group, an alkylthio group, a nitro group, a cyano group, and a substituent. And a carbamoyl group which may be used.
- R 3 is a benzoyl group which may be substituted, a phenyl group which may be substituted, a phenyl group which may be substituted, a phenyl group which may be substituted, an alkyl substituted by a phenyl which may be substituted.
- Examples of the type of the substituent include a halogen atom, an alkyl group, an alkoxy group, an alkylamino group, an alkylthio group, a nitro group, and a substituted rubamoyl group.
- heterocyclic ring represents an amino group which may be substituted with alkyl substituted with, thiophene, furan, imidazole, thiazol, oxazole, pyrazole, pyridine, pyrimidine, virazine, pyrrolidine, piperidine, piperazine
- substituent include halogen atoms, alkyl groups, alkoxy groups, alkylthio groups, alkylamino groups, nitro groups, carbamoyl groups which may be substituted, and the like.
- 5 is a lower alkyl group, a cycloalkyl group, a lower alkoxyalkyl group, an optionally substituted phenyl group, an optionally substituted N, S, or a 5- to 6-membered hetero ring containing 1 or 2 N, S, 0 (But bonded by an atom), an alkyl group substituted with an optionally substituted phenyl, an alkyl group substituted with an optionally substituted phenyl, and an alkyl group substituted with an optionally substituted pyridyl.
- R 1 m has the same meaning as described above.
- [— ⁇ ] can be obtained by reacting mn with an ammonium salt such as ammonium diacid in a solvent such as drip acid at a reaction temperature of 10 to 10 ° C.
- R 6 represents a lower alkoxycarbonyl group
- R 1 and m have the same meaning as described above.
- Examples of the solvent include alcohols such as methanol, ethanol and n-butanol, Ethers such as dioxane; aromatic hydrocarbons such as benzene and toluene; pyridine; DMF;
- Examples of the base include sodium methoxide, potassium metal butoxide and other metal alkoxides, organic bases such as triethylamine, N, N-dimethylaniline, pyridine and DBU, metal hydrides such as sodium hydride, and the like.
- Inorganic bases such as carbonated lime, sodium hydroxide, and silver carbonate are exemplified.
- R 7 is a lower alkoxy group, a cyano group, a halogen atom, a hydroxy group, a morpholino group, or an amino which may be substituted with a phenylalkyl or a lower alkyl which may be substituted.
- R 1 , m, and n have the same meaning as described above.
- [1′-4] can be obtained by reacting [ ⁇ 1] with an oxidizing agent such as metachloroperbenzoic acid and hydrogen peroxide in a solvent such as chloroform and sulfonic acid.
- an oxidizing agent such as metachloroperbenzoic acid and hydrogen peroxide
- a solvent such as chloroform and sulfonic acid.
- [I'-5] can be obtained by reacting [I'1-1] with a reducing agent such as sodium borohydride in a solvent such as methanol or ethanol.
- [I'16] can be obtained by reacting [ ⁇ 4] with a nucleophile in a solvent in the presence of a base.
- R 8 is a hydrogen atom, a lower alkoxy group, a lower alkyl group, a cycloalkyl group, a lower alkoxyalkyl group, a lower alkylthio group, a phenyl group which may be substituted.
- R 8 is a hydrogen atom, a lower alkoxy group, a lower alkyl group, a cycloalkyl group, a lower alkoxyalkyl group, a lower alkylthio group, a phenyl group which may be substituted.
- R represents an amino group which may be substituted with phenyl, lower alkoxy or lower alkyl which may be substituted
- R fl represents a lower alkyl group or a phenyl group which may be substituted
- R 1 and m are as defined above. Indicates the same meaning.
- [I ′ — 7] is a reaction of [ ⁇ ] and [Cor] in a solvent in the presence of a base at a reaction temperature of 10 It is obtained by reacting at 1010 ° C.
- the solvent examples include water, alcohols such as methanol, ethanol and n-butanol, ethers such as dioxane, aromatic hydrocarbons such as benzene and toluene, pyridine, DMF, and DMS0.
- Bases include sodium metal alkoxides such as sodium methoxide and potassium t-butoxide; organic bases such as triethylamine, N, N-dimethylaniline, pyridine and DBU; metal hydrides such as sodium hydride; And inorganic bases such as sodium hydroxide.
- [ ⁇ -8] can be obtained by reacting [ ⁇ -7] with a reducing agent such as sodium borohydride in a solvent such as methanol or ethanol.
- [1 'single 9] is [1' -7] and the R e S0 2 NH 2, DMF , in a solvent such as DMS 0, the reaction using a metal hydride such as hydride Natoriumu as base temperature 10-150 It is obtained by reacting at ° C.
- R 11 represents an optionally substituted phenyl group, an optionally substituted phenyl group or an optionally substituted pyridyl group
- R 1 , m, and R 2 each represent Has the same meaning as
- [— 12] is [1'-11] (synthesized under the same conditions as when [ ⁇ – 7] is produced using [ ⁇ ] as a raw material).
- Ethers such as dioxane and alcohols such as ethanol. It is obtained by heating to reflux for 1 to 24 hours with selenium dioxide in a solvent of benzene, water and mixtures thereof. Further, it can also be obtained by using an oxidizing agent such as chromic anhydride and manganese dioxide described in ACS Monograph 186 "Oxidations in Organic Chemistry 1990, 103-104.”
- R 1 , m and R 8 have the same meanings as described above.
- the compound of the formula [XII] is known or can be synthesized by a conventional method (for example, Tetrahedron, 42 (12), 3029-96 (1986)).
- the compound of the formula [1′-1 9] can be obtained by reacting under the same conditions as in the production of the compound of the [1′-1 7]. 8
- the compound of [1'-11] is heated in a solvent such as DMF, DMSO, or the like, or without solvent, with the compound of CI'10] and N, N-dimethylformamide dimethyl acetal, and then subjected to silica gel column chromatography. It is obtained by purification.
- the compound of the formula (xm) represents an active methylene compound, and R 12 and R 13 are the same or different and each represents a carbamoyl group which may be mono- or di-substituted by a cyano group, an alkoxycarbonyl group, or a lower alkyl group.
- the compound of the formula [1′—13] can be synthesized by a conventional method (Liebigs Ann. Chen 1984, 618-21).
- the compound of the formula ⁇ represents a primary amine, hydrazine, hydroxyamine or alkoxyamine, and R 14 is a lower alkyl group, an optionally substituted phenyl group, a lower alkoxy group, a lower alkylamino group, a hydroxy group, A phenylamino group and a lower alkoxycarbonylamino group.
- the compound [114] can be obtained by reacting a solvent in a solvent in the presence of an acid at a reaction temperature of 10 to 150 ° C.
- the solvent examples include alcohols such as methanol, ethanol and n-butanol, ethers such as dioxane, aromatic hydrocarbons such as benzene and toluene, halogenated carbons such as dichloromethane, chloroform, and 1,2-dichloroethane. Hydrogens, DMF, DMSO and the like.
- the acid examples include an inorganic acid such as hydrochloric acid and sulfuric acid, an organic acid such as oxalic acid and p-toluenesulfonic acid, and a Lewis acid such as boron trifluoride etherate.
- Examples of the solvent include water and halogenated hydrocarbons such as dichloromethane.
- Examples of the acid include inorganic acids such as hydrochloric acid and sulfuric acid.
- the desired product can be obtained by performing ordinary post-treatment.
- the structure of the compound of the present invention was determined from IR, NMR, MASS and the like. BEST MODE FOR CARRYING OUT THE INVENTION
- the chloroform layer was washed with water (5 Om 1 X 2) and dried over anhydrous magnesium sulfate, and chloroform was distilled off under reduced pressure.
- the SiE solution was poured into water (200 ml), extracted with black-mouthed form (3 Oml x 3), the mouth-shaped form layer was washed with water (5 Oml X2), dried over anhydrous magnesium sulfate, and then left on the mouth under ffi. I left.
- the residue was purified by column chromatography, and 0.55 g (m 155-6 ° C) of the 7-force rubamoinole form and 0.45 g (mp l 69- °) obtained.
- the mixture was washed with a 1 N hydrochloric acid, a 1 N aqueous sodium hydroxide solution and then with a saturated saline solution, and dried over anhydrous magnesium sulfate.
- the solvent was distilled off, and the resulting & ⁇ product was purified by silica gel column chromatography (eluent, glo-mouth form) to obtain the desired product (0.5 & 6 g, mp 15 3-6 ° C).
- the compound of the present invention has excellent bactericidal activity against a wide variety of fungi, various kinds of diseases that occur when agricultural and horticultural crops including flowers, grasses, grasses, and pastures are separated, especially powdery mildew Can be used to control downy mildew.
- powdery mildew of cucumber (Spha er 0 the c_a fu 1 iginea), powdery mildew of tomato (E rysipecico racea rum.), Powdery mildew of strawberry (Sphae ro the ca humu 1i), and tobacco Powdery mildew (E rysipheci cho racear um), Rinko's picky's disease CP odosphaera I euco tri cha), Oyster's powdery mildew (P hy 1 1 actinia kaki co la), Budow's picky vine (Uncinu) 1 an eca to r), downy mildew (P 1 as mo para viti co la), powdery mildew of pear CPhyl l ac t in iapyr)), powdery mildew of barley CErys iphe grami nisf.
- fungicides such as Sphae ro th eca iu ligi nea, which are resistant to benzimidazole fungicides (eg, thiophanate mel, benomyl, carbendazim), and ergosterol biosynthesis inhibiting fungicides (eg,
- the compounds of the present invention can be used against the fungus powdery mildew (Sha er 0t_t_he c_a fu 1 igi n_e a), which has reduced susceptibility to triadimefon and triflumizol, as well as the susceptible bacteria of these bacteria. It is valid.
- the compound of the present invention can also be used as an antifouling agent for preventing aquatic organisms from adhering to underwater objects such as ship bottoms and fishing nets.
- the thus-obtained compound of the present invention When the thus-obtained compound of the present invention is actually applied, no other component is added. It can be used in pure form or in the form of general pesticides for pesticide use, i.e., in the form of wettable powders, granules, powders, emulsions, aqueous solvents, suspensions, etc. it can. When a solid agent is used as an additive or carrier, it is possible to use soy flour, wheat flour and other vegetable powders, diatomaceous earth, limestone, gypsum, talc, pyrophyllite, clay, mineral oil, vegetable oil, etc. Mineral fine powder is used.
- liquid dosage forms use kerosene, mineral oil, petroleum, solvent naphtha, xylene, cyclohexane, cyclohexanone, dimethylformamide, dimethylsulfoxide, alcohol, acetone, mineral oil, vegetable oil, ⁇ , etc. Used as a solvent. Surfactants can be added, if necessary, to obtain a uniform and stable form in these preparations.
- the wettable powders, emulsions and suspensions thus obtained are diluted with water to a predetermined concentration and used as suspensions or emulsions. .
- the above mixture is mixed and wet-milled until the knee is less than 1 micron to obtain a 10% active ingredient suspension.
- the compound of the present invention is sufficiently effective alone, but it is one or two of various fungicides and insecticides and acaricides against inadequate or weak diseases or harmful insects and mites. It can be used in combination with the above.
- fungicides insecticides, acaricides, and plant growth regulators that can be used by mixing with the compound of the present invention are shown below.
- Gibberellins (eg Gibberellin A 3 , Gibberellin A 4 , Gibberellin A 7 ) I AA, NAA.
- Test Examples show that the compound of the present invention is useful as a crane component of various plant disease controlling agents.
- the control effect was evaluated by visually observing the diseased state of the test plant at the time of the survey, i.e., the appearance of the lesions on the leaves, stems, etc. Compared to untreated plots, 4% if recognized about 10%, 25%; 3J if recognized; 2% if about 50% recognized; 1J if 75% recognized, If there is no difference from the state, it is set to “0” and the efficiency is evaluated in six stages from 0 to 5, and is indicated by 0, 1, 2, 3, 4, and 5.
- Test Example 1 Wheat powdery mildew control test (prevention test)
- Leaves of open-grown grapes (variety "Kaiji", 3rd grade) cut out and punched into a 3 Omm-diameter disc are exposed to a chemical solution of a predetermined concentration of a wettable powder of the compound of the present invention.
- a suspension of zoospores of (P la sipop araviticola) was sprayed and inoculated, kept in a humidified room at 20 ° C under illumination, and the disease status was examined 10 days after the inoculation.
- Table 6 shows the results. Table 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
明 細 新規へテロ環誘導体及びその農園芸用殺菌剤 分野: SPECIFICATION New heterocyclic derivatives and fungicides for agricultural and horticultural use
本発明は、新規なヘテロ環誘導体及びその農園芸用殺菌剤に関する。 The present invention relates to a novel heterocyclic derivative and a fungicide for agricultural and horticultural use.
背景技術: Background technology:
農園芸作物の栽培に当り、 作物の病害に対して多数の防除薬剤が使用されてい るが、 その防除効力が不十分であつたり薬剤耐性の病原菌や害虫の出現によりそ の使用が制限されたりまた植物体に薬害や汚染を生じたり、 あるいは人畜魚類に 対する毒性が強かったりすることから、必ずしも満足すべき防除薬とは言い難い ものが少なくない。 従ってかかる欠点の少ない安全に使用できる薬剤の出現が強 く要請されている。 In the cultivation of agricultural and horticultural crops, a large number of control agents are used for crop diseases.However, their control efficacy is insufficient, and their use is limited due to the emergence of drug-resistant pathogens and pests. In addition, since many plants cause phytotoxicity and contamination, or are highly toxic to livestock and fish, many of them are not always satisfactory control agents. Therefore, there is a strong demand for a drug that can be used safely with few such disadvantages.
本発明の目的は、工業的に有利に合成でき効果力《確実で、 安全に使用できる農 園芸用殺菌剤となりうる新規化合物を提供することにある。 An object of the present invention is to provide a novel compound which can be advantageously synthesized industrially and which can be used as a fungicide for agricultural and horticultural use which is effective and secure and can be used safely.
本発明は、一般式 〔I〕 The present invention has the general formula (I)
〔I〕 [I]
〔式中、 mは 1〜4の整数、 R 1 は、 同一又は相異なって、水素原子、低級アル キル基、 低級アルコキシ基、 低級ハロアルコキシ基、 低級アルキルチオ基、低級 ハロアルキル基、低級アルコキシカルボニル基、 ニトロ基、 低級アルキルでモノ もしくはジ置換されてもよい力ルバモイル基またはハロゲン原子を表し、 Xは C = Z 〔Zは酸素原子、 CH(0H)、 Cr' (r2) 1、 r 2は同一又は相異なってシァノ 基、 アルコキシカルボニル基、 または低級アルキルでモノもしくはジ置換されて もよい力ルバモイル基を表す。 ) 、 Nr3 (r3は低級アルキル基、 置換されてもよ いフエニル基、低級アルコキシ基、低級アルキルアミノ基、 ヒドロキシ基、 置換 されてもよいフエニルァミノ基、低級アルコキシカルボニルァミノ基を表す。 ) 〕 、 CH(0H)、 CH2 を表し、 Yは N、 C(R4) (R4 は、水素原子、低級アルコキシカル ボニル基を表す。 ) を表し、 R2 は、水素原子、 S(0)„ r5 (r5は置換されてもよ い低級アルキル基、 nは 0、 1又は 2を表す。 )、低級アルコキシ基、低級アル キルスルホニルァミノ基、 置換されてもよぃフヱニルスルホニルァミノ基、 シァ ノ基、ハロゲン原子、 ヒドロキシ基、 モルホリノ基、又は置換されてもよいフエ ニルアルキルもしくは低級アルキルで置換されていてもよいァミノ基を、 R3 は、 水素原子、低級アルコキシ基、低級アルキル基、 シクロアルキル基、 置換されて もよいべンゾィノレ基、置換されてもよいチェ二ルカルポニル基、 置換されてもよ いピリジルカルボニル基、低級アルコキシアルキル基、低級アルキルチオ基、 置 換されてもよいフエニル基、置換されてもよい N, S, 0を 1〜2値含む 5〜6 員のへテロ環基、 置換されてもよいフエニルで置換されたアルキル基、 置換され てもよいチェニルで置換されたアルキル基、 置換されてもよいビリジルで置換さ れたアルキル基、又はシァノ、ニトロ、 N, S, 0を 1〜2個含む 5〜6員のへ テロ環で置換されたアルキル、 置換されてもよいフエニル、低級アルコキシもし くは低級アルキルで置換されてもよいアミノ基を表す。 〕 で表される化合物及び その塩の 1種又は 2種以上を含有する農園芸用殺菌剤である。 (In the formula, m is an integer of 1 to 4, R 1 is the same or different and is a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower haloalkoxy group, a lower alkylthio group, a lower haloalkyl group, a lower alkoxycarbonyl group, a nitro group, a mono- or di-optionally substituted force be Rubamoiru group or a halogen atom lower alkyl, X is C = Z [Z represents an oxygen atom, CH (0H), Cr ' (r 2) 1, r 2 is the same or different and represents a cyano group, an alkoxycarbonyl group, or a rubamoyl group which may be mono- or di-substituted by lower alkyl. ), Nr 3 (r 3 is a lower alkyl group, may be substituted A phenyl group, a lower alkoxy group, a lower alkylamino group, a hydroxy group, a phenylamino group and a lower alkoxycarbonylamino group which may be substituted. )], Represents CH (0H), CH 2 , Y represents N, C (R 4 ) (R 4 represents a hydrogen atom or a lower alkoxycarbonyl group.), R 2 represents a hydrogen atom, S (0) „r 5 (r 5 is a lower alkyl group which may be substituted, n represents 0, 1 or 2), a lower alkoxy group, a lower alkylsulfonylamino group, or a substituted R 3 represents a hydrogen atom, a phenylsulfonylamino group, a cyano group, a halogen atom, a hydroxy group, a morpholino group, or an amino group optionally substituted with phenylalkyl or lower alkyl which may be substituted; A lower alkoxy group, a lower alkyl group, a cycloalkyl group, an optionally substituted benzoinole group, an optionally substituted phenylcarbonyl group, an optionally substituted pyridylcarbonyl group, a lower alkoxyalkyl group, a lower alkylthio group, Replaced Phenyl group, 5- to 6-membered heterocyclic group containing 1-2 values of N, S, 0 which may be substituted, alkyl group substituted with phenyl which may be substituted, phenyl which may be substituted An alkyl group substituted with an optionally substituted viridyl, or an alkyl group substituted with a 5- to 6-membered heterocyclic ring containing 1 to 2 cyano, nitro, N, S, 0 And an amino group which may be substituted with phenyl, lower alkoxy or lower alkyl which may be substituted.] A fungicide for agricultural and horticultural use containing one or more of the compound represented by the formula: It is.
"^式 〔I〕 の置換基を更に説明する。 "^ The substituent of formula (I) will be further described.
r 3が置換されてもよいフエニル基、置換されてもよぃフヱニルァミノ基を表す 場合における置換基の種類としては、ハロゲン原子、 アルキル基、 アルコキシ基、 アルキルアミノ基、 アルキルチオ基、 シァノ基、 ニトロ基、 置換されてもよい力 ルバモイル基などが挙げられる。 When r 3 represents a phenyl group which may be substituted or a phenylamino group which may be substituted, examples of the substituent include a halogen atom, an alkyl group, an alkoxy group, an alkylamino group, an alkylthio group, a cyano group, and a nitro group. Group, an optionally substituted rubamoyl group and the like.
r5が置換されてもよ 、低級アルキル基を表す場合における置換基の種類として は、ハロゲン原子、 アルコキシ基、 アルキルチオ基、 アルキルアミノ基、 フエ二 ル基、 アルコキシカルボニル基、 置換されてもよいカノレバモイノレ基など力《挙げら れる。 r5が置換されてもよぃフヱニルスルホニルァミノ基を表す場合における置換基 の種類としては、 ハロゲン原子、 アルキル基、 アルコキシ基、 アルキルアミノ基、 アルキルチオ基、 ニトロ基、 シァノ基、 置換されてもよい力ルバモイル基などが 挙げられる。 R 5 may be substituted, and when it represents a lower alkyl group, examples of the substituent include a halogen atom, an alkoxy group, an alkylthio group, an alkylamino group, a phenyl group, an alkoxycarbonyl group, and a substituent. Power such as canolebamoinole group. When r 5 represents a phenylsulfonylamino group which may be substituted, examples of the substituent include a halogen atom, an alkyl group, an alkoxy group, an alkylamino group, an alkylthio group, a nitro group, a cyano group, and a substituent. And a carbamoyl group which may be used.
r 5が置換されてもよいフヱニルァルキルで置換されてもよいアミノ基を表す場 合におけるフヱニルアルキルの置換基の種類としては、ハロゲン原子、 アルキル 基、 アルコキシ基、 アルキルチオ基、 ニトロ基、 シァノ基、 アルキルアミノ基、 アルコキシカルボニル基、 置換されてもよいカル/くモィル基などが挙げられる。 The types of substituents Fuweniruarukiru in if r 5 represents an amino group which may be substituted by which may be Fuweniruarukiru substituted, a halogen atom, an alkyl group, an alkoxy group, an alkylthio group, a nitro group, Shiano group, an alkyl Examples include an amino group, an alkoxycarbonyl group, an optionally substituted cal / moyl group, and the like.
R3 が置換されてもよいベンゾィル基、置換されてもよいチェニルカルボニル 基、 置換されてもよいピリジルカルボニル基、 置換されてもよいフヱニル基、 置 換されてもよいフヱニルで置換されたアルキル基、 置換されてもよいチェニルで 置換されたアルキル基、 置換されてもよいピリジルで置換されたアルキル基、 又 は置換されてもよいフエニルで置換されてもよぃァミノ基を表す場合における置 換基の種類としては、 ハロゲン原子、 アルキル基、 アルコキシ基、 アルキルアミ ノ基、 アルキルチオ基、 ニトロ基、 置換されてもよい力ルバモイル基などが挙げ られる。 R 3 is a benzoyl group which may be substituted, a phenyl group which may be substituted, a phenyl group which may be substituted, a phenyl group which may be substituted, an alkyl substituted by a phenyl which may be substituted. Group, an alkyl group substituted with an optionally substituted phenyl, an alkyl group substituted with an optionally substituted pyridyl, or an amino group optionally substituted with an optionally substituted phenyl. Examples of the type of the substituent include a halogen atom, an alkyl group, an alkoxy group, an alkylamino group, an alkylthio group, a nitro group, and a substituted rubamoyl group.
R3 が置換されてもよい N, S, 0を 1〜2個含む 5〜6員のへテロ環基、 又 は N, S, 0を 1〜2個含む 5〜6員のへテロ環で置換されたアルキルで置換さ れてもよいアミノ基を表す場合におけるヘテロ環として、 チォフェン、 フラン、 イミダゾール、 チアゾ一ル、 ォキサゾール、 ピラゾール、 ピリジン、 ピリミジン、 ビラジン、 ピロリジン、 ピぺリジン、 ピペラジン、 モリホリン、 ピリジニゥムな どが挙げられ、 置換基の種類としては、 ハロゲン原子、 アルキル基、 アルコキシ 基、 アルキルチオ基、 アルキルアミノ基、 ニトロ基、 置換されてもよいカルバモ ィル基など力 <挙げられる。 本発明化合物は以下に示す方法により製造することができる c 5 to 6-membered heterocyclic group containing 1 to 2 N, S, 0, or 5 to 6-membered heterocyclic ring containing 1 to 2 N, S, 0, which R 3 may be substituted When the heterocyclic ring represents an amino group which may be substituted with alkyl substituted with, thiophene, furan, imidazole, thiazol, oxazole, pyrazole, pyridine, pyrimidine, virazine, pyrrolidine, piperidine, piperazine, Examples of the substituent include halogen atoms, alkyl groups, alkoxy groups, alkylthio groups, alkylamino groups, nitro groups, carbamoyl groups which may be substituted, and the like. The compound of the present invention can be produced by the following method c
① ①
CHaCOONHi/CHsCOOH CHaCOONHi / CHsCOOH
〔r一 i〕 [R-i]
式中、 5 は低級アルキル基、 シクロアルキル基、低級アルコキシアルキル基、 置換されてもよいフエニル基、 置換されてもよい N, S, 0を 1〜2個含む 5〜 6員のへテロ環基(但し、 原子で結合する)、 置換されてもよいフエニルで 置換されたアルキル基、 置換されてもよいチェニルで置換されたアルキル基、 置 換されてもよいピリジルで置換されたアルキル基を示し、 R1 mは前記と同じ 意味を示す。 In the formula, 5 is a lower alkyl group, a cycloalkyl group, a lower alkoxyalkyl group, an optionally substituted phenyl group, an optionally substituted N, S, or a 5- to 6-membered hetero ring containing 1 or 2 N, S, 0 (But bonded by an atom), an alkyl group substituted with an optionally substituted phenyl, an alkyl group substituted with an optionally substituted phenyl, and an alkyl group substituted with an optionally substituted pyridyl. And R 1 m has the same meaning as described above.
〔 —ι〕 は mn に、酔酸等の溶媒中、齚酸アンモニゥム等のアンモニゥ ム塩を反応温度 1 0〜1 0 o°cで反応させることにより得られる。 [—Ι] can be obtained by reacting mn with an ammonium salt such as ammonium diacid in a solvent such as drip acid at a reaction temperature of 10 to 10 ° C.
〔VI〕 [VI]
CH3I CH3I base CH 3 I CH 3 I base
式中 R6 は低級アルコキシカルボ二ル基を示し、 R1、 mは前記と同じ意味を 示す。 In the formula, R 6 represents a lower alkoxycarbonyl group, and R 1 and m have the same meaning as described above.
式 〔VI〕 および の化合物は公知であるか、 または常法により合成できる。 (薬学雑誌, 104 (2) , 127頁( 1984 ) ) 〔 I ' 一 2〕 および 〔 I ' 一 3〕 は、溶媒中、 塩基の存在下、 反応温度 10〜 100 °Cで反応させることに より得られる。 Compounds of formula [VI] and are known or can be synthesized by conventional methods. (Pharmaceutical Magazine, 104 (2), p. 127 (1984)) [I'12] and [I'13] are reacted at a reaction temperature of 10 to 100 ° C in a solvent in the presence of a base. Is obtained.
溶媒としては、 メタノール、 エタノール、 n—ブタノール等のアルコール類、 ジォキサン等のエーテル類、 ベンゼン、 トルエン等の芳香族炭化水素、 ピリジン、 DMF、 DMS O等が挙げられる。塩基としては、 ナトリウムメトキシド、 カリ ゥム t一ブトキシド等のアル力リ金属アルコキシド、 卜リェチルァミン、 N, N—ジメチルァ二リン、 ピリジン、 D B U等の有機塩基、 水素化ナトリゥム等の 金属水素化物、 炭酸力リゥム、水酸化ナトリウム、 炭酸銀等の無機塩基が挙げら れる。 Examples of the solvent include alcohols such as methanol, ethanol and n-butanol, Ethers such as dioxane; aromatic hydrocarbons such as benzene and toluene; pyridine; DMF; Examples of the base include sodium methoxide, potassium metal butoxide and other metal alkoxides, organic bases such as triethylamine, N, N-dimethylaniline, pyridine and DBU, metal hydrides such as sodium hydride, and the like. Inorganic bases such as carbonated lime, sodium hydroxide, and silver carbonate are exemplified.
③ ③
C I ' 一 5〕 cr 一 6〕 式中、 R7 は低級アルコキシ基、 シァノ基、 ハロゲン原子、 ヒドロキシ基、 モ ルホリノ基、又は置換されてもよいフヱニルアルキルもしくは低級アルキルで置 換されてもよいアミノ基を示し、 R1、 m、 nは前記と同じ意味を示す。 CI '5] cr-16] wherein R 7 is a lower alkoxy group, a cyano group, a halogen atom, a hydroxy group, a morpholino group, or an amino which may be substituted with a phenylalkyl or a lower alkyl which may be substituted. And R 1 , m, and n have the same meaning as described above.
〔1 ' —4〕 は、 〔Γ 一 1〕 に、 クロ口ホルム、酔酸等の溶媒中、 メタクロ 口過安息香酸、過酸化水素等の酸化剤を反応させることにより得られる。 [1′-4] can be obtained by reacting [Γ1] with an oxidizing agent such as metachloroperbenzoic acid and hydrogen peroxide in a solvent such as chloroform and sulfonic acid.
〔 I ' — 5〕 は、 メタノール、 エタノール等の溶媒中、 〔 I ' 一 1〕 に水素化 ホウ素ナトリゥム等の還元剤を反応させることにより得られる。 〔 I ' 一 6〕 は 〔 Γ 4〕 に、 溶媒中、 塩基の存在下、 求核剤を反応するこ とにより得られる。 [I'-5] can be obtained by reacting [I'1-1] with a reducing agent such as sodium borohydride in a solvent such as methanol or ethanol. [I'16] can be obtained by reacting [核 4] with a nucleophile in a solvent in the presence of a base.
④ ④
〔1 ' 一 9〕 〔1 ' 一 8〕 式中、 R8 は水素原子、低級アルコキシ基、低級アルキル基、 シクロアルキル 基、 低級アルコシキアルキル基、 低級アルキルチオ基、 置換されてもよいフエ二 ル基、 置換されてもよい Ν, S, 0を 1〜2個含む 5〜6員のへテロ環基、 置換 されてもよいフヱニルで置換されたァルキル基、 置換されてもよいチェニルで置 換されたアルキル基、 置換されてもよいピリジルで置換されたアルキル基、 又は シァノ、 ニトロ、 Ν, S , 0を 1〜2個含む 5〜6員のへテロ環で置換されたァ ルキル、 置換されてもよいフヱニル、低級アルコキシもしくは低級アルキルで置 換されてもよいアミノ基を示し、 Rfl は低級アルキル基又は置換されてもよいフ 二ル基を示し、 R 1 、 mは前記と同じ意味を示す。 [1′-1 9] [1′-1 8] wherein R 8 is a hydrogen atom, a lower alkoxy group, a lower alkyl group, a cycloalkyl group, a lower alkoxyalkyl group, a lower alkylthio group, a phenyl group which may be substituted. A 5- or 6-membered heterocyclic group containing 1 or 2 Ν, S, 0 which may be substituted, an alkyl group which may be substituted by phenyl, or a phenyl which may be substituted. A substituted alkyl group, an alkyl group substituted with an optionally substituted pyridyl, or an alkyl substituted with a 5- to 6-membered heterocyclic ring containing 1 to 2 cyano, nitro, Ν, S, 0, R represents an amino group which may be substituted with phenyl, lower alkoxy or lower alkyl which may be substituted, R fl represents a lower alkyl group or a phenyl group which may be substituted, and R 1 and m are as defined above. Indicates the same meaning.
〔I ' — 7〕 は、 〔Π〕 と 〔珊〕 とを、 溶媒中、 塩基の存在下、 反応温度 1 0 〜10 o°cで反応させることにより得られる。 [I ′ — 7] is a reaction of [Π] and [Cor] in a solvent in the presence of a base at a reaction temperature of 10 It is obtained by reacting at 1010 ° C.
溶媒としては、水、 メタノール、 エタノール、 n—ブタノール等のアルコール 類、 ジォキサン等のエーテル類、 ベンゼン、 トルエン等の芳香族炭化水素、 ピリ ジン、 DMF、 DMS 0等が挙げられる。塩基としてはナ卜リゥムメトキシド、 カリウム t一ブトキシド等のアル力リ金属アルコキシド、 卜リェチルァミン、 N, N—ジメチルァニリン、 ピリジン、 DBU等の有機塩基、水素化ナトリウム 等の金属水素化物、 炭酸力リゥム、水酸化ナトリゥム等の無機塩基が挙げられる。 Examples of the solvent include water, alcohols such as methanol, ethanol and n-butanol, ethers such as dioxane, aromatic hydrocarbons such as benzene and toluene, pyridine, DMF, and DMS0. Bases include sodium metal alkoxides such as sodium methoxide and potassium t-butoxide; organic bases such as triethylamine, N, N-dimethylaniline, pyridine and DBU; metal hydrides such as sodium hydride; And inorganic bases such as sodium hydroxide.
〔 Γ — 8〕 はメタノール、 エタノール等の溶媒中、 〔 Γ — 7〕 に水素化ホ ゥ素ナトリゥム等の還元剤を反応させることにより得られる。 [Γ-8] can be obtained by reacting [Γ-7] with a reducing agent such as sodium borohydride in a solvent such as methanol or ethanol.
〔1' 一 9〕 は、 〔1' -7〕 と ReS02NH2 を、 DMF、 DMS 0等の溶媒中、 水素化ナトリゥム等の金属水素化物を塩基として用いて反応温度 10-150°C で反応させることにより得られる。 [1 'single 9] is [1' -7] and the R e S0 2 NH 2, DMF , in a solvent such as DMS 0, the reaction using a metal hydride such as hydride Natoriumu as base temperature 10-150 It is obtained by reacting at ° C.
〔XI〕 C IA - 10〕 式中、 R 10は低級アルキル基を示し、 R8 は前記と同じ意味を示す。 〔 — 10〕 は I〕 とポリリン酸(ΡΡΑ) を 100〜2ひ 0°Cに加熱することによ り得られる。 ⑥ [XI] CI A -10] wherein R 10 represents a lower alkyl group, and R 8 has the same meaning as described above. [—10] can be obtained by heating I] and polyphosphoric acid (ΡΡΑ) to 100 ° C for 2 hours at 0 ° C. ⑥
〔Γ —11〕 〔 —12〕 式中、 R11は置換されてもよいフヱニル基、 置換されてもよいチェニル基又は 置換されてもよいピリジル基を示し、 R1、 m、 R2 は前記と同じ意味を示す。 [Γ—11] [—12] In the formula, R 11 represents an optionally substituted phenyl group, an optionally substituted phenyl group or an optionally substituted pyridyl group, and R 1 , m, and R 2 each represent Has the same meaning as
〔 — 12〕 は、 〔1 ' 一 11〕 ( 〔Ε〕 を原料に用いて 〔Γ — 7〕 を製 造する場合と同様の条件で合成される) ジォキサン等のエーテル類、 エタノール 等のアルコール類、 水及びそれらの混合物の溶媒中、二酸化セレンで 1〜24時 間、加熱還流することにより得られる。 また、 ACS Monograph 186 " Oxidations in Organic Chemistry 1990, 103— 104に記載さ れている無水クロム酸、二酸化マンガン等の酸化剤を用いても得ることができる。 ⑦ [— 12] is [1'-11] (synthesized under the same conditions as when [Γ – 7] is produced using [Ε] as a raw material). Ethers such as dioxane and alcohols such as ethanol. It is obtained by heating to reflux for 1 to 24 hours with selenium dioxide in a solvent of benzene, water and mixtures thereof. Further, it can also be obtained by using an oxidizing agent such as chromic anhydride and manganese dioxide described in ACS Monograph 186 "Oxidations in Organic Chemistry 1990, 103-104."
CXI) 〔I ' —9〕 式中、 R1、 m、 R8 は前記と同じ意味を示す。 CXI) [I′—9] In the formula, R 1 , m and R 8 have the same meanings as described above.
式 〔XII〕 の化合物は公知であるか、又は常法により合成できる (例えば、 Tetrahedron, 42 ( 12) , 3029— 96 (1986) )。 式 〔1 ' 一 9〕 の 化合物は 〔1 ' 一 7〕 の化合物を製造する場合と同様の条件で反応させることによ り得られる。 ⑧ The compound of the formula [XII] is known or can be synthesized by a conventional method (for example, Tetrahedron, 42 (12), 3029-96 (1986)). The compound of the formula [1′-1 9] can be obtained by reacting under the same conditions as in the production of the compound of the [1′-1 7]. ⑧
cr—10〕 cr-10]
CHOH CHOH
CI' 一 11〕 式中、 R1、 m、 R8、 Yは前記と同じ意味を示す。 CI′-11] wherein R 1 , m, R 8 and Y have the same meaning as described above.
〔1' 一 11〕 の化合物は DMF、 DMSO等の溶媒中、 あるいは無溶媒で、 CI ' 一 10〕 の化合物と N, N—ジメチルホルムアミドジメチルァセタールと 加熱還流した後、 シリカゲルカラムクロマトグラフィ一で精製することにより得 られる。 The compound of [1'-11] is heated in a solvent such as DMF, DMSO, or the like, or without solvent, with the compound of CI'10] and N, N-dimethylformamide dimethyl acetal, and then subjected to silica gel column chromatography. It is obtained by purification.
⑨ ⑨
CI' 一 12〕 CI'-1 12)
〔1' 一 13〕 式中、 R1、 m、 R8、 Yは前記と同じ意味を示す。 [1′-1 13] In the formula, R 1 , m, R 8 and Y have the same meaning as described above.
式 〔xm〕 の化合物は活性メチレン化合物を示し、 R12、 R 13は同一又は相異 なって、 シァノ基、 アルコキシカルボニル基、 低級アルキル基でモノもしくはジ 置換されてもよい力ルバモイノレ基を示す。 式 〔1 ' —13〕 の化合物は常法によ り合成できる ( Liebigs Ann. Chen 1984, 618— 21 ) 。 The compound of the formula (xm) represents an active methylene compound, and R 12 and R 13 are the same or different and each represents a carbamoyl group which may be mono- or di-substituted by a cyano group, an alkoxycarbonyl group, or a lower alkyl group. . The compound of the formula [1′—13] can be synthesized by a conventional method (Liebigs Ann. Chen 1984, 618-21).
© ©
CI ' 一 12〕 CI ' —14〕 式中、 R1 、 m、 R8 、 Yは前記と同じ意味を示す。 CI '1 12] CI'-14] In the formula, R 1 , m, R 8 and Y have the same meaning as described above.
式 ααπ の化合物は 1級ァミン、 ヒドラジン、 ヒドロキシアミン又はアルコ キシァミンを示し、 R14は低級アルキル基、 置換されてもよいフエニル基、低級ァ ルコキシ基、低級アルキルアミノ基、 ヒドロキシ基、 置換されてもよいフエニル アミノ基、低級アルコキシカルボニルァミノ基を示す。 The compound of the formula ααπ represents a primary amine, hydrazine, hydroxyamine or alkoxyamine, and R 14 is a lower alkyl group, an optionally substituted phenyl group, a lower alkoxy group, a lower alkylamino group, a hydroxy group, A phenylamino group and a lower alkoxycarbonylamino group.
〔 一 1 4〕 の化合物は溶媒中、酸の存在下、反応温度 1 0 - 1 5 0 °Cで反 応させることにより得られる。 The compound [114] can be obtained by reacting a solvent in a solvent in the presence of an acid at a reaction temperature of 10 to 150 ° C.
溶媒としてはメタノール、 エタノール、 n—ブタノール等のアルコール類、 ジ ォキサン等のエーテル類、 ベンゼン、 トルエン等の芳香族炭化水素類、 ジクロロ メタン、 クロ口ホルム、 1 , 2—ジクロロェタン等のハロゲン化炭化水素類、 D MF、 DMS O等が挙げられる。酸としては、塩酸、硫酸等の無機酸、 シユウ酸、 バラトルエンスルホン酸等の有機酸、三フッ化ホウ素エーテラー卜等のルイス酸 等が挙げられる。 Examples of the solvent include alcohols such as methanol, ethanol and n-butanol, ethers such as dioxane, aromatic hydrocarbons such as benzene and toluene, halogenated carbons such as dichloromethane, chloroform, and 1,2-dichloroethane. Hydrogens, DMF, DMSO and the like. Examples of the acid include an inorganic acid such as hydrochloric acid and sulfuric acid, an organic acid such as oxalic acid and p-toluenesulfonic acid, and a Lewis acid such as boron trifluoride etherate.
⑪ ⑪
C I ' 一 12〕 C I 'I 12)
C I ' —15〕 c 一 16〕 式中、 R1 、 m、 R8 、 Yは前記と同じ意味を示す。 式 〔Γ 一 1 5〕 及び 〔Γ 一 1 6〕 の化合物は、 溶媒中、 酸の存在下一 5〜 4 0 °Cで次亜塩素酸ナトリゥムを加えることにより得られる。 CI′—15] c-1 16] wherein R 1 , m, R 8 and Y have the same meaning as described above. The compounds of the formulas [Γ15] and [Γ16] can be obtained by adding sodium hypochlorite in a solvent at 15 to 40 ° C. in the presence of an acid.
溶媒としては水、 ジクロロメタン等のハロゲン化炭化水素等が挙げられる。 酸 としては、塩酸、 硫酸等の無機酸等が挙げられる。 Examples of the solvent include water and halogenated hydrocarbons such as dichloromethane. Examples of the acid include inorganic acids such as hydrochloric acid and sulfuric acid.
反応終了後は、通常の後処理を行うことにより目的物を得ることができる。 本 発明化合物の構造は、 I R、 NMR、 MA S S等から決定した。 発明を実施するための最良の形態: After completion of the reaction, the desired product can be obtained by performing ordinary post-treatment. The structure of the compound of the present invention was determined from IR, NMR, MASS and the like. BEST MODE FOR CARRYING OUT THE INVENTION
次に実施例、参考例を挙げて本発明を更に詳しく説明する。 Next, the present invention will be described in more detail with reference to Examples and Reference Examples.
参考例 1 Reference example 1
2 - 〔3—ォキソ一 3—フヱニルー 1—メチルチオプロピリデン〕 一インダン - 1 , 3—ジオン 2- [3-oxo-1-3-phenyl-1-methylthiopropylidene] 1-indane-1, 3-dione
2—ビス (メチルチオ) メチレン一インダン一 1 , 3—ジオン 1 2. 5 g、 ァセ トフヱノン 6. 0 g、 よくすりつぶした水酸化カリウム 6. 6 g及び無水 DMF 200 m 1を懸濁し、 室温で一晩攪拌した。 反応液を氷水中に注ぎ 1 N— H C 1を加え て p Hを 3〜4にした。 析出した結晶を減圧據過し、 乾燥して 2— 〔3—ォキソ 一 3—フエニル一 1ーメチルチオプロピリデン〕 一インダン一 1 , 3—ジオン 1 2 gを得た。 実施例 1 12.5 g of 2-bis (methylthio) methylene-indane-1,3-dione 12.5 g, 6.0 g of acetophenone, 6.6 g of well-ground potassium hydroxide and 200 ml of anhydrous DMF were suspended, and the mixture was suspended at room temperature. And stirred overnight. The reaction solution was poured into ice water, and the pH was adjusted to 3 to 4 by adding 1N—HC1. The precipitated crystals were filtered under reduced pressure and dried to obtain 12 g of 2- [3-oxo-13-phenyl-11-methylthiopropylidene] -1-indane-1,3-dione. Example 1
2—フエ二ルー 4ーメチルチオ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5 —オン (化合物番号 I一 3) 2-phenyl-2-methylthio-15H-indeno [1,2-b] pyridin-5-one (Compound No.I-13)
参考例 1で得られた化合物 12 g、醉酸ァンモニゥム 28.5 g及 酸 750 mlを 100°Cで 6時間攪拌し、一夜放置した。析出した結晶を濾過し、 ァセト ン、 エーテルで'洗浄して目的物を 4.5 g (m. p. 179 - 80 °C)を得た。 実施例 2 12 g of the compound obtained in Reference Example 1, 28.5 g of ammonium sulfate and 750 ml of acid were stirred at 100 ° C. for 6 hours, and left overnight. The precipitated crystals were filtered and washed with acetone and ether to obtain 4.5 g of the desired product (mp 179-80 ° C). Example 2
2- (2—メ トキシフエニル) 一4—メチルチオ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5—オン (化合物番号 1— 6) 2- (2-Methoxyphenyl) 1-4-methylthio-15H-indeno [1,2-b] pyridin-5-one (Compound No. 1-6)
2—ビス (メチルチオ) メチレン一インダン一 1, 3—ジオン 2.5 g、 2—メ トキシァセトフエノン 1.5 g、 よくすりつぶした水酸化力リウム 6.6 g及び無水 DMF4 Omlを懸濁し、 70でで 3時間、 続いて 1 00 °Cで 1時間攪拌した。 反応液を氷水中に注ぎ 1 N— H C 1を加え p Hを 3〜 4にして析出した結晶を減 圧濾過し、乾燥して 1.4 gの結晶を得た。 得られた結晶 1.4 gと酢酸アンモニゥ ム 3.07 gを酢酸 75mlに懸濁し、 100 °Cで 6時間攪拌した。 反応液を氷水 中に注ぎ、析出した結晶を濾取し乾燥した。 得られた粗生成物をシリカゲルカラ ムクロマトグラフィー (溶出液;クロ口ホルム)精製して、 目的物 0.4 g (mp 200 - 2 °C) を得た。 2.5 g of 2-bis (methylthio) methylene-indane-1,3-dione, 1.5 g of 2-methoxyacetophenone, 6.6 g of well-ground lithium hydroxide and 6.6 ml of anhydrous DMF4 were suspended, and the mixture was suspended at 70 for 3 hours. Subsequently, the mixture was stirred at 100 ° C for 1 hour. The reaction solution was poured into ice water, 1 N—HC1 was added to adjust the pH to 3 to 4, and the precipitated crystals were filtered under reduced pressure and dried to obtain 1.4 g of crystals. 1.4 g of the obtained crystals and 3.07 g of ammonium acetate were suspended in 75 ml of acetic acid and stirred at 100 ° C for 6 hours. The reaction solution was poured into ice water, and the precipitated crystals were collected by filtration and dried. The obtained crude product was purified by silica gel column chromatography (eluent; black form) to obtain 0.4 g (mp 200-2 ° C) of the desired product.
実施例 3 Example 3
2— (2—ヒドロキシフヱニル) 一 4ーメチルチオ一 5H—インデノ 〔1, 2 —b〕 ピリジン一 5—オン (化合物番号 I一 10) 2- (2-Hydroxyphenyl) -14-methylthio-5H-indeno [1,2—b] pyridin-5-one (Compound No. I-10)
2— (2—メ トキシフエニル) 一 4ーメチルチオ一 5H—インデノ 〔1, 2— b〕 ピリジン一 5—オン 0.95 gとピリジン塩酸塩 1 0 gを窒素雰囲気下で 150 °C20分攪拌した。放冷後氷一水を加えクロ口ホルム抽出し、 飽和食塩水で洗浄 した後、 無水硫酸マグネシウムで乾燥した。 溶媒を減圧留去して、 得られた !te 成物をシリカゲルカラムクロマトグラフィー (溶出液、 クロ口ホルム) で精製し て目的物 0.45 g (mp 228— 30°C) を得た。 0.95 g of 2- (2-methoxyphenyl) -14-methylthio-15H-indeno [1,2-b] pyridin-5-one and 10 g of pyridine hydrochloride were stirred under a nitrogen atmosphere at 150 ° C. for 20 minutes. After allowing to cool, ice-water was added, and the mixture was extracted with chloroform. The extract was washed with saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting! Te product was purified by silica gel column chromatography (eluent, chloroform) to obtain 0.45 g of the desired product (mp 228-30 ° C).
実施例 4 Example 4
2—フヱニル一 4—メチルスルフィ二ルー 5 H—インデノ 〔1, 2— b〕 ピリ ジン一 5—オン (化合物番号 1-11) 2-phenyl-1-4-methylsulfinyl 5-H-indeno [1,2-b] pyri 5-N-one (Compound No. 1-11)
2—フエニル一 4ーメチルチオ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5 一オン 0.64 gをクロ口ホルム 50mlに溶解し、 クロ口ホルム 20mlに溶解 したメタク口口過安息香酸 0.41 gを室温で滴下し 3時間攪泮した。 反応液を 1 N—水酸化ナトリウム水溶液、次いで飽和:^水で洗净した後、 無水硫酸マグネ シゥム- ^燥した。 溶媒を減圧留去し、得られた ite成物をシリ力ゲル力ラムク ロマ卜グラフィー (溶出液, クロ口ホルム)精製して目的物 0.55 g (mp 228 一 9。C)を得た。 Dissolve 0.64 g of 2-phenyl-14-methylthio-15H-indeno [1,2-b] pyridine-5-one in 50 ml of chloroform, and add 0.41 g of methacrylic acid perbenzoic acid dissolved in 20 ml of chloroform. The mixture was dropped at room temperature and stirred for 3 hours. The reaction solution was washed with a 1N aqueous solution of sodium hydroxide and then with saturated water, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained ite product was purified by silica gel gel chromatography (eluate, chloroform) to obtain 0.55 g of the desired product (mp 228-19.C).
実施例 5 Example 5
2—フエ二ルー 4—メチルスルホニルー 5 H—インデノ 〔1, 2-b] ピリジ ン一 5—オン Of匕合物番号 1—12) 2-phenyl-2-methylsulfonyl-5H-indeno [1,2-b] pyridin-1-5-ofofanimation compound number 1-12)
2—フエ二ルー 4ーメチルチオ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5 —オン 0.64 gをクロ口ホルム 5 Omlに溶解し、 クロ口ホルム 50mlに溶解 したメタクロ口過安息香酸 1.23 を滴下し、 1時間還流した。 放冷後反応液を 1 N—水酸化ナトリゥム水溶液、 次いで飽和食塩水で洗浄した後、 無水硫酸マグ ネシゥムで乾燥した。 溶媒を減圧留去し、 得られた粗生成物をシリカゲルカラム クロマトグラフィー (溶出液, クロ口ホルム)精製して目的物 0.4 g (mp 232 一 3 °C) を得た。 Dissolve 0.64 g of 2-phenyl-2-methylthio-15H-indeno [1,2-b] pyridin-5-one in 5 ml of chloroform and 5 ml of chloroform in 1.2 ml of metabenzoic perbenzoic acid. The mixture was added dropwise and refluxed for 1 hour. After allowing to cool, the reaction solution was washed with a 1 N aqueous solution of sodium hydroxide and then with a saturated saline solution, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (eluent, chloroform) to obtain 0.4 g (mp232-13 ° C) of the desired product.
実施例 6 Example 6
2—フエニル一 4—メ トキシ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5— オン (化合物番号 I一 13) 2-phenyl-1-4-methoxy-5 H-indeno [1,2-b] pyridine-15-one (Compound No. I-13)
2—フエニル一 4ーメチルスルホニル一 5 H—インデノ 〔1, 2— b〕 ピリジ ン一 5—オン 0,53 gをメタ.ノール 15mlに懸濁し、 28%ナトリゥムメチラ ートメタノール溶液 0.32 gを滴下し、 20分還流した。 反応液を氷一水中に注 ぎ、析出した結晶を濾取して乾燥した。 得られた胜成物をシリカゲルカラムク 口マトグラフィー (溶出液, クロ口ホルム) 精製して、 目的物 0.25 g (mp 192-5)を得た。 0.53 g of 2-phenyl-1-methylsulfonyl-5H-indeno [1,2-b] pyridin-5-one is suspended in 15 ml of methanol, and 0.32 g of a 28% sodium methanolate methanol solution is added dropwise. Refluxed for 20 minutes. The reaction solution was poured into ice and water, and the precipitated crystals were collected by filtration and dried. The resulting product was purified by silica gel column chromatography (eluate, black form) to obtain 0.25 g of the desired product (mp 192-5).
実施例 7 Example 7
2—フエ二ルー 4一 (ジメチルァミノ) 一 5 H—インデノ 〔1, 2— b〕 ピリ ジンー 5—オン (化合物番号 1-14) 2-phenyl-2- (dimethylamino) -5H-indeno [1,2-b] pyridin-5-one (Compound No. 1-14)
2—フエ二ルー 4ーメチルスルホニル一 5H—インデノ 〔1, 2— b〕 ピリジ ン一 5—オン 0.53 gを DMF 10mlに懸濁し、 50%ジメチルアミン水溶液 0. 3 gを加えた。 100°Cで 1時間攪掙した後、氷-水中に注ぎ、析出した結 晶をろ取して ¾ ^し、 目的物 0.38 g (mp 112 -4°C)を得た。 0.53 g of 2-phenyl-4-methylsulfonyl-5H-indeno [1,2-b] pyridin-15-one was suspended in 10 ml of DMF, and 0.3 g of a 50% aqueous dimethylamine solution was added. After stirring at 100 ° C for 1 hour, the mixture was poured into ice-water, and the precipitated crystals were collected by filtration and dried to obtain 0.38 g of the desired product (mp 112 -4 ° C).
実施例 8 Example 8
2—フエニル一 4—シァノ一5 H—インデノ 〔1, 2— b〕 ピリジン一 5—ォ ン (化合物番号 I一 15) 2-Phenyl-1-4-H-5-Indeno [1,2-b] Pyridine-15-one (Compound No. I-15)
2—フヱニルー 4—メチルスルホニルー 5 H—インデノ 〔1, 2— b〕 ピリジ ン一 5—オン 0.53 g、 シアン化ナトリウム 0.26 gを DMSO 10 m 1に懸 濁し、 60 °Cで 10分攪拌した。 放冷後反応液を氷一水中に注ぎ析出した結晶を ろ取し、 水で十分洗浄して乾燥し、 目的物 0.25 g (mp 245— 6°C) を得た。 実施例 9 2-Phenyl-4-methylsulfonyl-5H-indeno [1,2-b] pyridin-5-one 0.53 g and sodium cyanide 0.26 g were suspended in 10 ml of DMSO and stirred at 60 ° C for 10 minutes. . After allowing to cool, the reaction solution was poured into ice-water and the precipitated crystals were collected by filtration, washed sufficiently with water and dried to obtain 0.25 g (mp 245-6 ° C) of the desired product. Example 9
2—メ トキシー 3—メ トキシカルボ二ルー 4ーメチルチオ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5—オン (化合物番号 1—16) 2-Methoxy 3 -Methoxycarboxy 4-methylthio-1 5H-indeno [1,2-b] pyridin-5-one (Compound No. 1-16)
2, 5—ジヒドロー 3—メ 卜キシカルボ二ルー 4ーメチルチオ一 1H—インデ ノ 〔1, 2—b〕 ピリジン一 2, 5—ジオン 1.5 gを無水 DMF 1 5m 1に溶解 し 60%水素化ナ卜リゥムオイルディスパージヨンを 0.2 g加え室温で 1 5分攪 拌して、 ヨウ化メチルを L 4 g加え一夜攪拌した。 反応液を氷一水中に注ぎベン ゼン抽出し、飽和食塩水で洗浄後無水硫酸マグネシウムで乾燥した。溶媒を減圧 留去して得られた 物をシリ力ゲル力ラムクロマトグラフィー (溶出液, ベ ンゼン)精製して、 目的物 0.1 g (m 145-7°C)を得た。 2,5-Dihydro-3-methoxycarbonyl-2-methylthio-1H-indeno [1,2-b] pyridine 1,2,5-dione 1.5 g is dissolved in anhydrous DMF 15 ml 1 and 60% hydrogenated sodium hydrogen Add 0.2 g of real oil dispersion and stir at room temperature for 15 minutes After stirring, 4 g of methyl iodide was added and the mixture was stirred overnight. The reaction solution was poured into ice water and extracted with benzene, washed with saturated saline and dried over anhydrous magnesium sulfate. The product obtained by distilling off the solvent under reduced pressure was purified by silica gel gel column chromatography (eluent, benzene) to obtain 0.1 g of the desired product (m 145-7 ° C).
実施例 10 Example 10
2—フヱニルー 4ーメチルチオ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5 —オール(化合物番号 Π— 4 ) 2-Phenyl-5-methylthio-15H-indeno [1,2-b] pyridin-5-ol (Compound No. Π-4)
2—フヱニルー 4—メチルチオ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5 —オン 0.3 g、水素化ホウ素ナトリウム 0.25 gをエタノール 20mlに懸濁し、 室温で 2時間攪摔した。 SiS液を氷-水中に注ぎ、 1 -HC 1を加え弱酸性に して、析出した結晶をろ取し乾燥した。得られた 物をシリカゲルカラムク 口マトグラフィー (溶出液, クロ口ホルム)精製して目的物 0.23 s (mp 200 一 3°C)を得たひ 0.3 g of 2-phenyl-4-methylthio-15H-indeno [1,2-b] pyridin-5-one and 0.25 g of sodium borohydride were suspended in 20 ml of ethanol and stirred at room temperature for 2 hours. The SiS solution was poured into ice-water, 1-HC1 was added to make it slightly acidic, and the precipitated crystals were collected by filtration and dried. The obtained product was purified by silica gel column chromatography (eluent, chromatographic form) to obtain the desired product 0.23 s (mp 200-13 ° C).
実施例 11 Example 11
2—フエ二ルー 4ーメチルチオ一 5 H—インデノ 〔1, 2— d〕 ピリミジン一 5—オン (化合物番号 1—5) 2-phenyl-2-methylthio-5H-indeno [1,2-d] pyrimidin-5-one (Compound No. 1-5)
2—ビス (メチルチオ) メチレン一インダン一 1, 3—ジオン 2.3 g、 ベンズ ァミジン塩酸塩 1.83 g及び炭酸力リゥム 1.27 gを無水 DMFに懸濁し、 50 〜60°Cで 1時間攪拌した。反応液を氷一水中に注ぎ、 ベンゼン抽出して、有機 層を飽和食塩水で洗浄した後、 無水硫酸マグネシゥムで乾燥した。 溶媒を減圧留 去して、 得られた粗生成物をベンゼン一へキサンから再結晶して目的物を 1.0 g (mp 228 - 9 °C) を得た。 2.3 g of 2-bis (methylthio) methylene-indane-1,3-dione, 1.83 g of benzamidine hydrochloride and 1.27 g of carbonic acid rim were suspended in anhydrous DMF and stirred at 50 to 60 ° C for 1 hour. The reaction solution was poured into ice water and extracted with benzene, and the organic layer was washed with saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained crude product was recrystallized from benzene-hexane to obtain 1.0 g (mp 228-9 ° C) of the desired product.
実施例 12 Example 12
2— (6—メチルー 2—ピリジル) 一 4—メチルチオ一 5 H—インデノ 〔1, 2-d] ピリミジン一 5—オール (化合物番号 H— 3) 2- (6-Methyl-2-pyridyl) -14-methylthio-5H-indeno [1,2-d] pyrimidin-5-ol (Compound No.H-3)
2 Two
2 Two
Nゝ 3 N ゝ 3
2- (6—メチル一2—ピリジル) 一4ーメチルチオ一 5H—インデノ 〔1, 2— d〕 ピリミジン一 5—オン 0.6 g、水素化ホウ素ナトリウム 0.5 gをェタノ ール 30mlに懸濁し、室温で 2時間攒拌した。反応液を氷一水中に注ぎ 1N— HC1を加え中和して、析出した結晶をろ取し乾燥した。得られた 成物をシ リ力ゲレカラムクロマ卜グラフィー (溶出液, クロ口ホルム)精製して目的物 0.51 g (mp 204 - 6 °C)を得た。 2- (6-Methyl-1-pyridyl) 1-4-methylthio-5H-indeno [1,2-d] pyrimidin-5-one 0.6 g and sodium borohydride 0.5 g are suspended in 30 ml of ethanol, and the suspension is carried out at room temperature. The mixture was stirred for 2 hours. The reaction solution was poured into ice water and neutralized by adding 1N-HC1, and the precipitated crystals were collected by filtration and dried. The resulting product was purified by silica gel column chromatography (eluate, black form) to obtain 0.51 g of the desired product (mp 204-6 ° C).
5— (N, N—ジメチルカルバモイル) 一インダン一 1, 3-ジオン 5- (N, N-dimethylcarbamoyl) 1-indan-1,3-dione
無水酢酸 (3 L7 g) に、 4— (N, N—ジメチルカルバモイル)無水フタル 酸(13.5 g, 61.6讓 ol) とァセト酔酸 t—ブチル(19.5 g, 123腿 ol) とを加え、 トリェチルァミン (12.5 g, 123腿01) を滴下し、 70〜80°C で 4時間反応させた。 反応後減圧下に過剰の無水酢酸と、 生じた酢酸を留去し、 残渣を水 (200ml) と濃塩酸 (13ml) より調製した塩酸水に注加し、 ク ロロホルム (50m 1 X 5)で抽出した。 To 4- (N, N-dimethylcarbamoyl) phthalic anhydride (13.5 g, 61.6 benzyl) and t-butyl acetohydrate (19.5 g, 123 t ol) were added to acetic anhydride (3 L7 g), and triethylamine was added. (12.5 g, 123 thigh 01), and drop at 70-80 ° C For 4 hours. After the reaction, excess acetic anhydride and generated acetic acid were distilled off under reduced pressure, and the residue was poured into aqueous hydrochloric acid prepared from water (200 ml) and concentrated hydrochloric acid (13 ml), and added with chloroform (50 ml × 5). Extracted.
クロ口ホルム層を水洗 (5 Om 1 X 2)後無水硫酸マグネシウムで乾燥し、 ク ロロホルムを減圧下に留去した。 The chloroform layer was washed with water (5 Om 1 X 2) and dried over anhydrous magnesium sulfate, and chloroform was distilled off under reduced pressure.
この残渣をクロ口ホルム一エーテルの混合溶媒を加えて結晶化させ、表記化合 物 5.4 g (mp 133〜5°C) を得た。 The residue was crystallized by adding a mixed solvent of black form-ether to give 5.4 g (mp 133-5 ° C) of the title compound.
参考例 3 Reference example 3
2—ビス (メチルチオ) メチレン一 5— (N, N—ジメチルカルバモイル) 一 インダン一 1, 3—ジオン 2-bis (methylthio) methylene-1-5- (N, N-dimethylcarbamoyl) -1-indane-1,3-dione
5— (N, N—ジメチルカルバモイル) 一インダン一 1, 3—ジオン (5g, 23.26腿 ol)を、 DMF (50ml) に溶解した。 この溶液に水酸化ナ卜リウ ム (1.86 g, 46.5腿 ol)を水 (5m 1 ) に溶解した液を室温にて加えたあと、 二硫化炭素 (2.65 g, 34.9讓 ol)を室温にて滴下し、 そのまま 2時間攪拌し た。 この溶液に、 水冷下ヨウ化メチル( 13.2 g, 93腿 ol) を 1時間かけて滴 下し、 さらに一夜攪拌した。 反応液を水(300ml) にあけ、 生ずる結晶を濾 取、水洗、 乾燥し、 エーテルより再結晶した。 収量 6.0 g, 収率 80%, mp 145〜7。C 5- (N, N-Dimethylcarbamoyl) -indane-1,3-dione (5 g, 23.26 tmol) was dissolved in DMF (50 ml). To this solution was added a solution of sodium hydroxide (1.86 g, 46.5 t) dissolved in water (5 ml) at room temperature, and then carbon disulfide (2.65 g, 34.9 ol) at room temperature. The mixture was added dropwise and stirred for 2 hours. To this solution, methyl iodide (13.2 g, 93 tmol) was added dropwise over 1 hour under water cooling, followed by stirring overnight. The reaction solution was poured into water (300 ml), and the resulting crystals were collected by filtration, washed with water, dried and recrystallized from ether. Yield 6.0 g, 80% yield, mp 145-7. C
実施例 13 Example 13
2—メチルー 4ーメチルチオ一 7— (N, N—ジメチルカルバモイル) 一 5H 一インデノ 〔1, 2— d〕 ピリ ミジン一 5—オン及び、 2—メチル一4—メチル チォー 8— (N, N—ジメチルカルバモイル) 一 5 H—インデノ 〔1, 2— d〕 ピリ ミジン一 5—才ン ({匕合物番号 HE— 1, E-2) 2-Methyl-4-methylthio-17- (N, N-dimethylcarbamoyl) -5H-indeno [1,2-d] pyrimidin-5-one and 2-methyl-14-methylthio-8- (N, N- Dimethylcarbamoyl) 1 5 H-indeno [1, 2-d] Pyrimidine-1 5 years old ({Dragon compound number HE-1, E-2)
2—ビス (メチルチオ) メチレン一 5— (N, N—ジメチルカルバ'モイル) - インダン一 1, 3-ジオン (1.50g, 4.67腿01) を DMF (30ml) に溶 解し、 この溶液にァセ卜アミジン塩酸塩(0.44 g, 4.67臓 ol) と、無水炭酸 力リゥ厶 (0.64 g, 467mmol) を加えて、 60 °〜70 °Cで一夜反応させた。 SiE液を水(200ml) にあけ、 クロ口ホルム (3 Oml x 3)抽出し、 クロ 口ホルム層を水洗 (5 Oml X2) し、無水硫酸マグネシウムで乾燥後、 クロ口 ホルムを ffi下に留去した。 その残渣をカラムクロマトグラフィーで精製し、表 言 &f匕合物のうちの 7—力ルバモイノレ体を 0.55 g (m 155— 6 °C)、 8—力 ルバモイル体を 0.45 g (mp l 69— 70° )得た。 2-bis (methylthio) methylene-1-5- (N, N-dimethylcarba'moyl) -indane-1,3-dione (1.50 g, 4.67 / 1) was dissolved in DMF (30 ml) and added to this solution. Cetamidine hydrochloride (0.44 g, 4.67 g ol) and anhydrous carbon dioxide (0.64 g, 467 mmol) were added, and the mixture was reacted overnight at 60 to 70 ° C. The SiE solution was poured into water (200 ml), extracted with black-mouthed form (3 Oml x 3), the mouth-shaped form layer was washed with water (5 Oml X2), dried over anhydrous magnesium sulfate, and then left on the mouth under ffi. I left. The residue was purified by column chromatography, and 0.55 g (m 155-6 ° C) of the 7-force rubamoinole form and 0.45 g (mp l 69- °) obtained.
実施例 14 Example 14
2—メチルー 4ーメチルスルホニルァミノ一 5 H—インデノ 〔1, 2— d〕 ピ リミジン一 5—オン (化合物番号 E— 13 ) 2-Methyl-4-methylsulfonylamino-5H-indeno [1,2-d] pyrimidin-5-one (Compound No.E-13)
60%水素化ナトリゥムオイルデスパージヨン 0· 0 8 gを無水 DMF 5mlに 懸濁し 0 °Cに冷却して、 メタンスルホンアミ ド 0.1 9 gを少量ずつ加えた。 20 分攪拌した後、 2—メチル一4ーメチルチオ一 5 H—インデノ 〔1, 2— d〕 ピ リミジン一 5—オン 0.48 gを加え室温で一夜攪拌した。 さらに徐々に昇温し 1 20°Cで 2時間攪拌した。 放冷後氷—水中に注ぎ 1 N—塩酸で酸性にし、析出 した結晶を乾燥し、 シリカゲルカラムクロマトグラフィー (溶出液, メタノール :クロ口ホルム = 1 : 9)精製して目的物 0.1 5 g (mp 1 85 - 7 °C) を得た。 参考例 4 0.8 g of 60% hydrogenated sodium oil despurgeon was suspended in 5 ml of anhydrous DMF, cooled to 0 ° C, and 0.19 g of methanesulfonamide was added little by little. After stirring for 20 minutes, 0.48 g of 2-methyl-1-methylthio-15H-indeno [1,2-d] pyrimidin-1-one was added, and the mixture was stirred at room temperature overnight. The temperature was further raised gradually, and the mixture was stirred at 120 ° C for 2 hours. After allowing to cool, pour into ice-water, acidify with 1N-hydrochloric acid, dry the precipitated crystals, and purify by silica gel column chromatography (eluent, methanol: chloroform = 1: 1: 9) to obtain 0.15 g of the desired product ( mp 1 85-7 ° C). Reference example 4
2, 4ージフヱニルピリ ミジン一 5—力ルボン酸ェチル 2,4-diphenylpyrimidine 5-ethyl ether
3—ジメチルァミノ一 2—べンゾィルァクリル酸ェチル 2 g、 ベンズァミジン 塩酸塩 1.25 g、 炭酸力リウム 1.1 gを無水 D M Fに懸濁し 70 °Cで 2時間攪拌 した。放冷後反応液を氷一水中に注ぎベンゼン抽出し、飽和: ft^7]で洗浄した後 無水硫酸マグネシウムで乾燥した。 溶媒を減圧留去して得られた 成物をシリ 力ゲルカラムクロマトグラフィー (溶出液, 酢酸ェチル:ベンゼン =1 r 3)精 製して目的物 L 56 g (mp 50-2°C)を得た。 3-Dimethylamino-2-ethyl benzoyl acrylate 2 g, benzamidine hydrochloride 1.25 g, and lium carbonate 1.1 g are suspended in anhydrous DMF and stirred at 70 ° C for 2 hours. did. After allowing to cool, the reaction solution was poured into ice-water and extracted with benzene, washed with saturated solution: ft ^ 7], and dried over anhydrous magnesium sulfate. The product obtained by evaporating the solvent under reduced pressure was purified by silica gel column chromatography (eluent, ethyl acetate: benzene = 1 r3) to obtain 56 g of the desired product L (mp 50-2 ° C). Obtained.
-参考例 5 -Reference example 5
2, 4-ジフヱニルピリミジン一 5—力ルボン酸 2,4-diphenylpyrimidine-1-5-Rubonic acid
2, 4—ジフエ二ルピリミジン一 5—力ルボン酸ェチル 1.56 gをメタノール 16mlに溶解し、 50 °Cに加熱した。水 7 m 1に溶解した炭酸ナトリゥムを加 え 5時間還流した。 冷却後水を加え 1 N—塩酸で酸性にし、 クロロホルム抽出し た後、飽和:^水で洗净し、無水硫酸マグネシウムで乾燥した。 溶媒を減圧留去 して目的物を 1.1 g得た。 1.56 g of 2,4-diphenylpyrimidine-15-potassium ethyl rubonate was dissolved in 16 ml of methanol and heated to 50 ° C. Sodium carbonate dissolved in 7 ml of water was added and refluxed for 5 hours. After cooling, water was added, the mixture was acidified with 1N-hydrochloric acid, extracted with chloroform, washed with saturated water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 1.1 g of the desired product.
実施例 15 Example 15
2—フエニル一 5H—インデノ 〔1, 2— d〕 ピリミジン一 5—オン(化合物 1-1 ) 2-Phenyl-1-H-indeno [1,2-d] pyrimidin-5-one (Compound 1-1)
2, 4-ジフエニルピリミジン一 5—力ルボン酸 0.4 gとポリリン酸 6.1 gを 窒素雰囲気下、 170°Cで一夜攪拌した。 放冷後水を加えてクロ口ホルム抽出し、 飽和食塩水で洗浄後、 無水硫酸マグネシウムで乾燥した。 溶媒を減圧留去して得 られた粗生成物をシリ力ゲル力ラムクロマトグラフィー (溶出液, メタノール: クロ口ホルム = 1 : 9)精製して目的物 0.2 g (mp 171— 3°C) を得た。 実施例 16 0.4 g of 2,4-diphenylpyrimidine-1-5-carboxylic acid and 6.1 g of polyphosphoric acid were stirred overnight at 170 ° C. under a nitrogen atmosphere. After cooling, water was added, and the mixture was extracted with chloroform. The extract was washed with saturated saline and dried over anhydrous magnesium sulfate. The crude product obtained by evaporating the solvent under reduced pressure was purified by silica gel gel chromatography (eluent, methanol: chloroform = 1: 9) and the desired product was purified to 0.2 g (mp 171-3 ° C). I got Example 16
2—ベンゾィル一4ーメチルチオ一 5 H—インデノ 〔1, 2— d〕 ピリミジン 一 5—オン (化合物番号]!一 26) 2-Benzyl-1-methylthio-5H-indeno [1,2-d] pyrimidin-5-one (Compound No.!-26)
2—べンジルー 4ーメチルチオ一 5 H—インデノ 〔1, 2— d〕 ピリ ミジン一 5—オン 1.3 gをジォキサン 1 3mlと水 0.6m 1に懸濁し、 二酸化セレン 1.4 gを加え 2時間還流した。 反応液をセライ 卜ろ過し、 ろ液に水および酢酸ェチル を加え分液した。 有機層を飽和食塩水で洗浄した後、 無水硫酸マグネシウムで乾 燥した。 溶媒を減圧留去して得られた 成物をシリカゲルカラムクロマトグラ フィ一 (溶出液; クロ口ホルム:へキサン 1 : 1)精製して、 目的物 0.14 g (mp 21 1 - 4 °C) を得た。 例 6 1.3 g of 2-benzyl-4-methylthio-5H-indeno [1,2-d] pyrimidin-5-one was suspended in 13 ml of dioxane and 0.6 ml of water, and 1.4 g of selenium dioxide was added thereto and refluxed for 2 hours. The reaction solution was filtered through celite, and water and ethyl acetate were added to the filtrate to separate the filtrate. The organic layer was washed with a saturated saline solution and dried over anhydrous magnesium sulfate. The product obtained by distilling off the solvent under reduced pressure is purified by silica gel column chromatography (eluent; chromate form: hexane 1: 1), and the desired product is 0.14 g (mp 21 1-4 ° C) I got Example 6
2 - 〔3—ォキソ一3— (4一ピリジル) 一1ーメチルチオプロピリデン〕 一 インダン一 1 , 3—ジオン \ 2-[3-oxo-3- (4-pyridyl) -1-methylthiopropylidene] one indane one 1,3-dione \
6 0 %水素化ナトリウムオイルデスパージヨン 8. 0 gを無水 DMF 3 0 0 m l 中に懸濁させ、 4一ァセチルビリジンを滴下した。 室温で 2 0分攪拌して、 2 - ビス (メチルチオ) メチレン一インダン一 1 , 3—ジオン 2 5 gを加え室温で一 晚攪摔した。 SiSS液を氷水中に注ぎ 1 N—塩酸を加えて p H 7にし、析出した結 晶をろ取し乾燥した。得られた ffi ^物をシリカゲルカラムクロマトグラフィー (溶出液、 クロ口ホルム)精製して、 目的物 1 8. 6 gを得た。 8.0 g of 60% sodium hydride oil despargeon was suspended in 300 ml of anhydrous DMF, and 4-acetylviridine was added dropwise. The mixture was stirred at room temperature for 20 minutes, 25 g of 2-bis (methylthio) methylene-indan-11,3-dione was added, and the mixture was stirred at room temperature for 1 minute. The SiSS solution was poured into ice water, 1 N hydrochloric acid was added to adjust the pH to 7, and the precipitated crystals were collected by filtration and dried. The obtained ffi product was purified by silica gel column chromatography (eluate, liquid form) to obtain 18.6 g of the desired product.
モルホリン一 1—カルボキシァミジン確酸塩 Morpholine mono 1-carboxyamidine acid salt
誦 3 Recitation 3
NH NH
0 N-C 画 3 0 NC image 3
Hz モルホリン 4.35 gと 3 , 5—ジメチルピラゾールー 1―力ルボキシアミジン 硝酸塩 2.0 1 gを窒素雰囲気下で 3時間還流した。 過剰のモルホリンを減圧留去 し、 得られた粗生成物に醉酸ェチルを加え水で抽出した。 水層を減圧留去し、 目 的物 2.5 gを得た。 Hz 4.35 g of morpholine and 2.0 1 g of 3,5-dimethylpyrazole-1-carboxamidine nitrate were refluxed under a nitrogen atmosphere for 3 hours. Excess morpholine was distilled off under reduced pressure, and ethyl acetate was added to the obtained crude product, followed by extraction with water. The aqueous layer was distilled off under reduced pressure to obtain 2.5 g of the target substance.
実施例 17 Example 17
2— (4—ピリジル) 一 4ーメチルチオ一5H—インデノ 〔1, 2— d〕 ピリ ミジン一 5—オン (化合物番号 1—8) 2- (4-pyridyl) -1-methylthio-5H-indeno [1,2-d] pyrimidin-5-one (Compound No. 1-8)
2—ビス (メチルチオ) メチレン一インダン一 1, 3—ジオン 16.32 g, 4 一ピリジンカルボキシアミジン塩酸塩 10.22 g及び炭酸力リゥム 9.01 gを無 水 DM Fに懸濁し 70-80°Cで 1時間攪拌した。 反応液を水一氷中に注ぎ、 析 出した結晶をろ取した。 水、 へキサンで洗浄し乾燥して目的物 16.1 9 g (mp 267 - 9 °C) を得た。 16.32 g of 2-bis (methylthio) methylene-indane-1,3-dione, 10.22 g of 4-pyridinecarboxyamidine hydrochloride and 9.01 g of carbonic acid rim are suspended in anhydrous DMF and stirred at 70-80 ° C for 1 hour. did. The reaction solution was poured into water and ice, and the precipitated crystals were collected by filtration. The extract was washed with water and hexane and dried to obtain 16.19 g of the desired product (mp 267-9 ° C).
実施例 18 Example 18
2—モルホリノー 4—メチルチオ一 5 H—インデノ 〔1, 2— d〕 ピリミジン 一 5—オン (化合物番号 Π— 4 1) 2-morpholino 4-methylthio-5H-indeno [1,2-d] pyrimidin-5-one (Compound No. Π—41)
2—ビス (メチルチオ) メチレン一インダン一 I, 3—ジオン 3*13 g, モル ホリン一 1一カルボキシァミジン硝酸塩 2.4 g及び炭酸力リゥム 1.73 gを無水 DMFに懸濁し、 70〜80°Cで 4時間攪拌した。反応液を氷一水中に注ぎ、析 出した結晶をろ取し乾燥した。得られた 3te成物をク口口ホルム一へキサンから 再結晶して目的物 1.2 5 g (mp 237 -8°C) を得た。 Suspension of 2-bis (methylthio) methylene-indane-1 I, 3-dione 3 * 13 g, morpholine-111-carboxyamidine nitrate 2.4 g and carbonic acid lime 1.73 g in anhydrous DMF, 70-80 ° C Stir for 4 hours. The reaction solution was poured into ice and water, and the precipitated crystals were collected by filtration and dried. The obtained 3te product was recrystallized from phenol-form-hexane to obtain 1.25 g of the desired product (mp 237 -8 ° C).
実施例 1 9 Example 19
2—フエ二ルー 4ーメチルチオ一 5 H—インデノ 〔1, 2— d〕 ビリ ミジン (化合物番号 It— 6) 2-phenyl-2-methylthio-5H-indeno [1, 2-d] birimidine (Compound No. It— 6)
2 -ビス (メチルチオ) メチレンィンダノン 2.36 g、 ベンズァミジン塩酸塩 1.57 g及び炭酸カリウム 1.38 gを無水 DMFに懸濁し、 70〜80°Cで 2時 間攪拌した。 反応液を氷一水中に注ぎ、 ベンゼン抽出し、 飽和食塩水で洗浄した 後、 無水硫酸マグネシウムで乾燥した。 溶媒を減圧留去して、 得られた粗生成物 をシリカゲルカラムクロマトグラフィー (溶出液、 ベンゼン)精製して、 目的物 0.87 g (mp 137 - 9 °C) を得た。 2.36 g of 2-bis (methylthio) methylene indanone, 1.57 g of benzamidine hydrochloride and 1.38 g of potassium carbonate were suspended in anhydrous DMF and stirred at 70 to 80 ° C. for 2 hours. The reaction solution was poured into ice-water, extracted with benzene, washed with saturated saline, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained crude product was purified by silica gel column chromatography (eluent, benzene) to obtain 0.87 g of the desired product (mp 137-9 ° C).
実施例 20 Example 20
2 -フエ二ルー 4—メチルチオ一 5—ヒドロキシメチリデン一 5H—ィンデノ 〔1, 2— d〕 ピリミジン一 5—オン (化合物番号 m— 8) 2-phenyl-2-methylthio-5-hydroxymethylidene-5H-indeno [1,2-d] pyrimidin-5-one (compound number m-8)
2—メチルー 4ーメチルチオ一 5H—インデノ 〔1, 2— d〕 ピリミジン 0.29 gを N, N—ジメチルホルムアミ ドジメチルァセタール 0.6 gに溶解し、 1時間 還流した。 反応後過剰のァセタールを減圧留去し、得られたジメチルァミノメチ レン体をシリカゲルカラムクロマトグラフィー (溶出液、 ベンゼン) にかけるこ とにより加水分解して、 目的物 0.12 g (mp 24 1 -3°C dec) を得た。 実施例 21 0.29 g of 2-methyl-4-methylthio-5H-indeno [1,2-d] pyrimidine was dissolved in 0.6 g of N, N-dimethylformamide dimethyl acetal and refluxed for 1 hour. After the reaction, excess acetal was distilled off under reduced pressure, and the obtained dimethylaminomethylene was hydrolyzed by subjecting it to silica gel column chromatography (eluent, benzene) to give 0.12 g of the desired product (mp 24 1- 3 ° C dec). Example 21
2—フエ二ルー 4一べンジルチオ一 5 H—インデノ 〔1, 2— b〕 ピリジン一 5—オン (化合物番号 1— 19) 2-Fueneru 4-Benzylthio-5-H-indeno [1,2-b] pyridin-5-one (Compound No. 1-19)
60 %水素化ナトリゥムオイルディスパージョン 0.0 & gを無水 DMF 15 ml中に懸濁し、無水 DMF 5mlに溶解したベンジルメルカブタン 0.2 gを 滴下した。室温で 5分攪拌した後、 2—フェニルー 4ーメチルスルホニル一 5 H —インデノ 〔1, 2— b〕 ピリジン一 5—オン 0.53 gを加え、 100でで1時 間攪拌した。 冷却後氷一水中に注ぎクロ口ホルム抽出した後、飽和食塩水で洗浄 し、無水硫酸マグネシウムで乾燥した。 溶媒を ffi留去して得られた ½成物を シリカゲルカラムクロマトグラフィー(溶出液、 クロ口ホルム)精製して目的物 0.35 g (mp I 56 - 8 °C)を得た。 60% hydrogenated sodium oil dispersion 0.0 & g was suspended in 15 ml of anhydrous DMF, and 0.2 g of benzyl mercaptan dissolved in 5 ml of anhydrous DMF was added dropwise. After stirring at room temperature for 5 minutes, 0.53 g of 2-phenyl-4-methylsulfonyl-15H-indeno [1,2-b] pyridin-5-one was added, and the mixture was stirred at 100 for 1 hour. After cooling, the mixture was poured into ice water and extracted with black hole form, washed with saturated saline and dried over anhydrous magnesium sulfate. The resulting product obtained by evaporating the solvent was purified by silica gel column chromatography (eluent, chloroform) to obtain 0.35 g of the desired product (mp I 56-8 ° C).
実施例 22 Example 22
〔2— C4- (1—メチノレ) ピリジニゥム〕 一 4ーメチルチオ一 5H—インデ ノ 〔1, 2— d〕 ピリミジン一 5—オン〕 ィオダイド(ィ匕合物番号 E— 32) [2-C4- (1-Methynole) pyridinium] 1-4-methylthio-15H-indeno [1,2-d] pyrimidin-5-one] iodide
2- (4一ピリジル) 一 4ーメチルチオ一 5 H—インデノ 〔1, 2— d〕 ピリ ミジン一 5—オン 0.23 "及びヨウ化メチル 0.35 gをジォキサン 10m 1に加 え 5時間還流した。 放冷後、 析出した結晶をろ取し目的物 0.23 g (mp 270 °C以上) を得た。 2- (4-Pyridyl) -14-methylthio-15H-indeno [1,2-d] pyrimidin-5-one 0.23 "and methyl iodide 0.35 g were added to dioxane 10m1. The mixture was refluxed for 5 hours. After cooling, the precipitated crystals were collected by filtration to obtain 0.23 g (mp: 270 ° C or more) of the target product.
NMR (DMSO) : 62.8 ppm (s, 3H) , 4.5 (s, 3 H) , 7.8 (m, NMR (DMSO): 62.8 ppm (s, 3H), 4.5 (s, 3H), 7.8 (m,
3H) , 8.0 (d, 1H) , 9.0 (d, 2H) , 9.2 (d, 2H) 3H), 8.0 (d, 1H), 9.0 (d, 2H), 9.2 (d, 2H)
実施例 23 Example 23
2— (4一ピリジル) 一 4ーメチルチオ一 5—エトキシカルボニルヒドラゾノ 一 5 H—インデノ 〔1, 2— d〕 ピリミジン一 5—オン (化合物番号 11—5) 2- (4-Pyridyl) -14-methylthio-5-ethoxycarbonylhydrazono-5H-indeno [1,2-d] pyrimidin-5-one (Compound No. 11-5)
2— (4—ピリジル) 一4ーメチルチオ一 5H—インデノ 〔1, 2— d〕 ピリ ミジン _ 5—オン 0.53 g、 ェチルカーバゼー卜 0.20 g及びパラトルエンスル ホン酸一水和物 0.1 gを DMSO 10m 1とトルエン 10mlに加え、 ジーン スタークを用いて水を留去しながら 2時間還流した。 放冷後、析出した結晶をろ 取し、 エーテル洗浄して目的物 0.43 g (mp 246— 8°C) を得た。 2- (4-pyridyl) 1-4-methylthio-5H-indeno [1,2-d] pyrimidin-5-one 0.53 g, ethylcarbazate 0.20 g and paratoluenesulfonate monohydrate 0.1 g in DMSO 10m 1 And toluene (10 ml), and the mixture was refluxed for 2 hours while distilling off water using Gene Stark. After allowing to cool, the precipitated crystals were collected by filtration and washed with ether to give 0.43 g of the desired product (mp 246-8 ° C).
実施例 24 Example 24
2一フエ二ルー 4—メチルチオ一 5—ビス (エトキシカルボニル) メチリデン — 5 H—インデノ 〔1 , 2— d〕 ピリミジン一 5—オン (化合物番号 IE— 1 0 ) 2-phenyl 4-methylthio-5-bis (ethoxycarbonyl) methylidene — 5 H—indeno [1, 2—d] pyrimidine-1-5-one (Compound No. IE—10)
窒素雰西気下で、 2—フエニル一 4—メチルチオ一 5 H—インデノ 〔1 , 2— d〕 ピリミジン一 5—オン 0. 7 2 gとマロン酸ジェチル 0. 5 7 gをジクロロメ タン 2 Omlに溶解し、 0 °Cに冷却して四塩化チタン 1. 5 m 1を滴下した。 0でで 2 0分攒 ^、無水ピリジンを 2 2 m 1滴下した。 0でで 2時間、室温で 2時間 反応させ、氷一水中に注ぎ、 クロ口ホルム抽出した。 1 N—塩酸、 1 N—水酸ィ匕 ナトリウム水溶液、次いで飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥し た。溶媒を 留去して得られた & ^物をシリカゲルカラムクロマトグラフィ- (溶出液、 グロ口ホルム)で精製して目的物 0. & 6 g (mp 1 5 3— 6 °C) を得 た。 Under a nitrogen atmosphere, 2-phenyl-14-methylthio-15H-indeno [1,2-d] pyrimidin-5-one 0.72 g and getyl malonate 0.57 g in dichloromethane 2 Oml And cooled to 0 ° C., and 1.5 ml of titanium tetrachloride was added dropwise. At 0 ° for 20 minutes, 22 ml of anhydrous pyridine was added dropwise. The reaction was carried out at 0 for 2 hours and at room temperature for 2 hours, poured into ice-water and extracted with black-mouthed form. The mixture was washed with a 1 N hydrochloric acid, a 1 N aqueous sodium hydroxide solution and then with a saturated saline solution, and dried over anhydrous magnesium sulfate. The solvent was distilled off, and the resulting & ^ product was purified by silica gel column chromatography (eluent, glo-mouth form) to obtain the desired product (0.5 & 6 g, mp 15 3-6 ° C).
実施例 2 5 Example 2 5
2—フエニル一 4ーメチルチオ一 5—エトキシィミノー 5 H—インデノ 〔1, 2— d〕 ピリミジン一 5—オン (化合物番号 M— 9 ) 2-Phenyl-1-methylthio-5-ethoxymino 5 H-indeno [1,2-d] pyrimidin-5-one (Compound No. M-9)
2—フヱニルー 4ーメチルチオ一 5 H—インデノ 〔1, 2— d〕 ピリ ミジン一 5—オン 1.01 g及びエトキシアミン 0.43 gを 1, 2—ジクロロェタン 10ml に懸濁し、三フッ化ホウ素エーテラ一トを 0.3ml加え 4時間還流した。 放冷後 溶媒を減圧留去し、得られた粗生成物をシリ力ゲル力ラムクロマトグラフィー (溶出液、 クロ口ホルム:へキサン = 1 : 1) で精製し、 目的物 1.1 g (mp 160— 2 °C) を得た。 1.01 g of 2-phenyl-4-methylthio-5H-indeno [1,2-d] pyrimidin-5-one and 0.43 g of ethoxyamine are suspended in 10 ml of 1,2-dichloroethane, and boron trifluoride etherate is suspended in 0.3 ml. After adding ml, the mixture was refluxed for 4 hours. After cooling, the solvent was distilled off under reduced pressure, and the resulting crude product was purified by silica gel chromatography (eluent, chloroform: hexane = 1: 1) to obtain 1.1 g of the desired product (mp 160 — 2 ° C).
実施例 26 Example 26
2—フエ二ルー 4ーメチルスルホニルー 5 H—インデノ 〔1, 2— d〕 ピリミ ジンー5—オン及び 2—フエ二ルー 4一クロロー 5H—インデノ 〔1, 2— d〕 ピリミジン一 5—オン (化合物番号]! - 54, 1- 55) 2-phenyl-2-methylsulfonyl-5H-indeno [1,2-d] pyrimidin-5-one and 2-phenyl-2-chloro-5H-indeno [1,2-d] pyrimidin-5-one (Compound number)!-54, 1- 55)
2—フエ二ルー 4ーメチルチオ一 5Η—インデノ 〔1, 2— d〕 ピリ ミジン一 5—オン 1.52 g、 濃塩酸 2.5ml、 水 37.5mlをジクロロメタン 12.5ml に溶解し 0 °Cに冷却した。 5 %次亜塩素酸ナ卜リゥム水溶液 18.8 gを滴下し、 0°Cで 5時間攪拌した。 有機層を分離し飽和食塩水で洗浄した後、 無水硫酸マグ ネシゥムで乾燥した。溶媒を減圧留去して、得られた ffi ^成物をカラムクロマト グラフィー (溶出液、 クロ口ホルム)精製し、表記化合物のうちクロル体 0. 3 8 g (mp 1 8 4— 7 °C)、 スルホ二ル体を 0. 3 0 g (mp 2 3 0— 3 °C)得た。 上記実施例を含め、本発明化合物の代表例を第 1表、第 2表、第 3表に示す。 1.52 g of 2-phenyl-2-methylthio-5-indeno [1,2-d] pyrimidin-5-one, 2.5 ml of concentrated hydrochloric acid and 37.5 ml of water were dissolved in 12.5 ml of dichloromethane and cooled to 0 ° C. 18.8 g of a 5% aqueous solution of sodium hypochlorite was added dropwise, and the mixture was stirred at 0 ° C for 5 hours. After separating the organic layer and washing with saturated saline, anhydrous magnesium sulfate Dried with Nesium. The solvent was distilled off under reduced pressure, and the resulting ffi ^ product was purified by column chromatography (eluent, chromatographic form), and 0.38 g of the chloro form of the title compound (mp 1 8 4-7 ° C ) And 0.30 g of a sulfonyl compound (mp 230-3 ° C) were obtained. Representative examples of the compounds of the present invention, including the above Examples, are shown in Tables 1, 2 and 3.
第 1 First
構 造 式 Structural formula
物理恒数 化合物 〔 〕 mp 番 号 CO Physical constant compound [] mp number CO
R! R4 R ! R 4
I一 1 SCH3 H 〔218-20〕 I-I 1 SCH 3 H [218-20]
I一 2 -0CH3 〔172-5〕 I-1 2 -0CH 3 (172-5)
1 -3 C179 - 80〕 1 -3 C179-80)
1 -4 CI 〔239-41〕 1 -4 CI [239-41]
1 -5 [253-5〕 1 -5 [253-5]
I一 6 〔200-2〕 I-1 6 (200-2)
1 -7 H3 〔190-3〕 1 -7 H 3 (190-3)
I一 8 CH3 〔180-2〕 (つづさ) I-1 8 CH 3 (180-2) (Continued)
(つづき) (Continued)
搆 Iron
物理恒数 化合物 〔 〕 mp 番 号 (。C) Physical constant compound [] mp number (.C)
R2 R 2
I一 1 SCH3 -CHs 〔213-4〕 I-I 1 SCH 3 -CHs [213-4]
IE— 2 〔138-40〕 IE-2 [138-40]
E-3 し C151-2〕 E-3 then C151-2]
CHs CHs
1-4 -C-CH3 〔127-8〕 1-4 -C-CH3 (127-8)
CHs -5 〔228-9〕 -6 〔220-2〕 -7 〔237-8〕 -8 〔267-9〕 (つづき) CHs -5 (228-9) -6 (220-2) -7 (237-8) -8 〔267-9〕 (Continued)
CH3 CH 3
1-9 SCH3 〔236 - 7〕 1-9 SCH 3 [236-7]
I -10 -0CH3 〔215-6〕 I -10 -0CH 3 (215-6)
E-11 〃 -SCH3 〔234-6〕 ノ CH3 E-11 〃 -SCH 3 [234-6] NO CH3
1-12 〔244-5〕 1-12 (244-5)
CH3 CH 3
1-13 -NHSO2CH3 -CH3 〔185-7〕 1-13 -NHSO2CH3 -CH 3 (185-7)
1-14 H 〔171-3〕 1-14 H [171-3]
CH3 CH 3
-15 〃 -6 〔158-9〕 -16 〃 〔198-200〕 -17 〃 〔239-41〕 -18 SCH3 - HCH3 〔248 - 250〕 -19 〃 -NH2 〔270以上〕 (つづき) -15 〃 -6 [158-9] -16 〃 [198-200] -17 〃 [239-41] -18 SCH 3 -HCH3 [248-250] -19 〃 -NH2 [270 or more] (Continued)
(つづき) (Continued)
(つづき) (Continued)
〕 (つづき) ] (Continued)
第 2 表 (つづき) Table 2 (continued)
I一 59 -SCH3 〔218-21〕 -匿 (DMSO- de-CDCl3), δ: ppm I-59 -SCH 3 (218-21) - Anonymous (DMSO- d e -CDCl 3), δ: ppm
U 2.5 (s, 3H), 7.3 (s, broad 2H) , 7.6 (m, 4H) U 2.5 (s, 3H), 7.3 (s, broad 2H), 7.6 (m, 4H)
*5 2.6(s, 3H), 7.7 Cm, 4H) * 5 2.6 (s, 3H), 7.7 Cm, 4H)
(IR(KBr): 1 co 1700 cm一1 レ CN 2200 cm—1)(IR (KBr): 1 co 1700 cm-1 1 CN 2200 cm— 1 )
δ: ppm δ: ppm
ネ 6 2.8(s,H), 4.5(s, 3H), 7.8(m,3H), 8.0(d, IH), 9.0(d, 2H), D 6 2.8 (s, H), 4.5 (s, 3H), 7.8 (m, 3H), 8.0 (d, IH), 9.0 (d, 2H),
9.2(d,2H) 9.2 (d, 2H)
Π L6(t, 3H), 2.8(s, 3H), 4.8(q,2H), 7.8(m,3H), 8.0(d, IH), 9.0(d, 2H), 9.3(d, 2H) Π L6 (t, 3H), 2.8 (s, 3H), 4.8 (q, 2H), 7.8 (m, 3H), 8.0 (d, IH), 9.0 (d, 2H), 9.3 (d, 2H)
*8 1.7(d,6H), 2.8(s, 3H), 5.2(m,lH), 7.8(m.3H), 8. l(d, IH), 9.0(d,2H), 9.4(d,2H) * 8 1.7 (d, 6H), 2.8 (s, 3H), 5.2 (m, lH), 7.8 (m.3H), 8.l (d, IH), 9.0 (d, 2H), 9.4 (d, 2H)
*9 2.8(s, 3H), 4.0(m,2H), 4.8(m, 2H), 7.8.(m,3H), 8.0(d, IH), 9.0(d,2H), 9.2(d, 2H) * 9 2.8 (s, 3H), 4.0 (m, 2H), 4.8 (m, 2H), 7.8. (M, 3H), 8.0 (d, IH), 9.0 (d, 2H), 9.2 (d, 2H) )
^- MRCCDCls), δ: ppm ^-MRCCDCls), δ: ppm
o 2.3(s, 3H), 2.4Cs, 3H), 2.5(s, 3H), 2.60n,2H), 3.4(d, 3H), 3.9 Cm, 2H), L6(m,4H) o 2.3 (s, 3H), 2.4Cs, 3H), 2.5 (s, 3H), 2.60n, 2H), 3.4 (d, 3H), 3.9 Cm, 2H), L6 (m, 4H)
物理恒数 化合物番号 式 〔 〕 mp Physical constant Compound number Formula [] mp
CO CO
n— 1 〔155-6〕 n-1 (155-6)
4 Four
7 7
Π-2 〔169-70〕 Π-2 [169-70]
m-3 〔204-6〕 m-3 〔204-6〕
m— 4 [200-3〕 (つづき) m—4 [200-3] (Continued)
M-5 〔 246-8〕 M-5 [246-8]
Π-6 〔 137-9〕 Π-6 [137-9]
Π-7 〔 253-4〕 Π-7 [253-4]
CHOH CHOH
SCHs SCHs
m-8 〔241-3〕 dec m-8 (241-3) dec
N N
N (つづき) N (Continued)
N0C2H N0C 2 H
m-9 〔 160-2〕 m-9 (160-2)
Et02C C02Et Et0 2 C C0 2 Et
\ / \ /
Π- 1 0 C 153-6〕 Π- 10 C153-6)
m— 1 1 〔 263-4 3 m— 1 1 [263-4 3
本発明化合物は、広範囲の種類の糸伏菌に対しすぐれた殺菌力をもっているこ と力、ら、花卉、芝、牧草を含む農園芸作物の離に際し発生する種々の病害、 と くにうどんこ病やべと病の防除に使用すること力出来る。 たとえば、 キユウリの うどんこ病(Spha e r 0 t h e c_a f u 1 i g i n e a)、 トマトのうど んこ病 (E r y s i p e c i c o racea r um.)、 ィチゴのうどんこ 病(Sphae ro the ca humu 1 i )、 タバコのうどんこ病(E r y s i p h e c i cho racear um)、 リンコのつどん'こ病 CP o d o s p h a e r a I euco t r i cha)、 カキのうどんこ病 (P h y 1 1 a c t i n i a kaki co l a)、 ブドヴのつどんこ两 (U n c i n u 1 a n eca to r)、ベと病 (P 1 a s mo para v i t i co l a) 、 ナシの うどんこ病 CPhyl l ac t in i a p y r ί )、 ォォムギのうどんこ病 CErys iphe grami n i s f . s p. ho rde i)、 コムギの うどんこ病(E r y s i p h e g r am i n i s f . s p. t r i t i c i) 、 ォーチヤ一ドグラスのうどんこ病 CE r y s i phe g r am i n i s)、 ヒ マヮリのうどんこ病 Spiiae ro the ca f u l i g i nea)、 ガ一 ベラのうどんこ病 (S ae ro the ca f u l i ginea) s ノ ラの うどんこ病(S p h a e r o t h e c a p anno s a)などの病害防除に使 用することが出来る。 The compound of the present invention has excellent bactericidal activity against a wide variety of fungi, various kinds of diseases that occur when agricultural and horticultural crops including flowers, grasses, grasses, and pastures are separated, especially powdery mildew Can be used to control downy mildew. For example, powdery mildew of cucumber (Spha er 0 the c_a fu 1 iginea), powdery mildew of tomato (E rysipecico racea rum.), Powdery mildew of strawberry (Sphae ro the ca humu 1i), and tobacco Powdery mildew (E rysipheci cho racear um), Rinko's picky's disease CP odosphaera I euco tri cha), Oyster's powdery mildew (P hy 1 1 actinia kaki co la), Budow's picky vine (Uncinu) 1 an eca to r), downy mildew (P 1 as mo para viti co la), powdery mildew of pear CPhyl l ac t in iapyr)), powdery mildew of barley CErys iphe grami nisf. S p. Ho rde i), wheat powdery mildew (E rysiphegr am inisf .sp. tritici), ochidodograsu powdery mildew CE rysi phe gr am inis), Himaury powdery mildew Spiiae ro the ca fuligi nea) I Bella powdery mildew (S ae ro the ca fuli ginea) (S p h a e r o t h e c a p anno s a) can be used in disease control, such as.
また、 ベンズイミダゾール系殺菌剤(例えば、 チオファネートメ ル、 べノミ ル、 カルベンダジム) に耐性を示すキユウリうどんこ病菌 (Sphae ro th e c a iu l i g i nea)や、 エルゴステロール生合成阻害型の殺菌剤(例 えば、 卜リアジメホン、 トリフルミゾ一ル) に感受性力低下しているキユウリう どんこ病菌 (S ha e r 0 t_he c_a f u 1 i g i n_e a) に対しても本発 明化合物はこれら菌の感受性菌と同様に有効である。 In addition, fungicides such as Sphae ro th eca iu ligi nea, which are resistant to benzimidazole fungicides (eg, thiophanate mel, benomyl, carbendazim), and ergosterol biosynthesis inhibiting fungicides (eg, For example, the compounds of the present invention can be used against the fungus powdery mildew (Sha er 0t_t_he c_a fu 1 igi n_e a), which has reduced susceptibility to triadimefon and triflumizol, as well as the susceptible bacteria of these bacteria. It is valid.
本発明化合物は、 水棲生物が船底、漁網等の水中接触物に付着するのを防止す るための防汚剤として使用することも出来る。 The compound of the present invention can also be used as an antifouling agent for preventing aquatic organisms from adhering to underwater objects such as ship bottoms and fishing nets.
このようにして得られた本発明化合物を実際に施用する際には他成分を加えず 純粋な形で使用できるし、 また農薬として使用する目的で一般の農薬のとり得る 形態、即ち、 水和剤、 粒剤、粉剤、 乳剤、 水溶剤、 懸濁剤等の形態で使用するこ ともできる。 添加剤および担体としては固型剤を目的とする場合は、 大豆粉、 小 麦粉等の植物性粉末、珪藻土、 燃灰石、 石こう、 タルク、 パイロフィライト、 ク レイ、 鉱物油、植物油等の鉱物性微粉末が使用される。 液体の剤型を目的とする 場合は、 ケロシン、鉱油、 石油、 ソルベントナフサ、 キシレン、 シクロへキサン、 シクロへキサノン、 ジメチルホルムアミ ド、 ジメチルスルホキシド、 アルコール、 アセトン、 鉱物油、 植物油、 τΚ等を溶剤として使用する。 これらの製剤において 均一かつ安定な形態をとるために、必要ならば界面活性剤を添加することもでき る。 このようにして得られた水和剤、 乳剤、 懸濁剤は水で所定の濃度に希釈して 懸濁液あるいは乳濁液として、 粉剤 ·粒剤はそのまま植物に散布する方法で使用 される。 When the thus-obtained compound of the present invention is actually applied, no other component is added. It can be used in pure form or in the form of general pesticides for pesticide use, i.e., in the form of wettable powders, granules, powders, emulsions, aqueous solvents, suspensions, etc. it can. When a solid agent is used as an additive or carrier, it is possible to use soy flour, wheat flour and other vegetable powders, diatomaceous earth, limestone, gypsum, talc, pyrophyllite, clay, mineral oil, vegetable oil, etc. Mineral fine powder is used. For liquid dosage forms, use kerosene, mineral oil, petroleum, solvent naphtha, xylene, cyclohexane, cyclohexanone, dimethylformamide, dimethylsulfoxide, alcohol, acetone, mineral oil, vegetable oil, τΚ, etc. Used as a solvent. Surfactants can be added, if necessary, to obtain a uniform and stable form in these preparations. The wettable powders, emulsions and suspensions thus obtained are diluted with water to a predetermined concentration and used as suspensions or emulsions. .
次に、 本発明の組成物の実施例を若干示すが、 添加物及び添加割合は、 これら 実施例に限定されるべきものではなく、 広い範囲に変ィ匕させることが可能である。 製剤実施例中の部は重量部を示す。 Next, some examples of the composition of the present invention will be described. However, the additives and the addition ratio should not be limited to these examples, but can be varied over a wide range. Parts in Formulation Examples are parts by weight.
実施例 2 7 水和剤 Example 2 7 wettable powder
本発明化合物 4 0部 Compound of the present invention 40 parts
珪藻土 5 3部 Diatomaceous earth 5 3 parts
高級アルコール硫酸エステル 4部 Higher alcohol sulfate 4 parts
アルキルナフタレンスルホン酸塩 3部 Alkyl naphthalene sulfonate 3 parts
以上を均一に混合して微細に粉砕すれば、 有効成分 4 0 %の水和剤を得る。 実施例 2 8 乳剤 If the above are uniformly mixed and finely pulverized, a wettable powder with an active ingredient of 40% is obtained. Example 28 Emulsion
本発明化合物 3部 Compound of the present invention (3 parts)
キシレン 4 5部 Xylene 4 5 parts
ジメチルホルムアミ ド 4 5部 Dimethylformamide 4 5 parts
ポリオキシエチレンアルキルァリルエーテル 7部 Polyoxyethylene alkylaryl ether 7 parts
以上を混合溶解すれば、 有効成分 3 %の乳剤を得る。 実施例 2 9 粉剤 By mixing and dissolving the above, an emulsion containing 3% of the active ingredient is obtained. Example 2 9 Dust
本発明化合物 1 0部 Compound of the present invention 10 parts
タルク 8 9部 Talc 8 9 parts
ポリオキシエチレンアルキルァリルエーテル 1部 1 part of polyoxyethylene alkylaryl ether
以上を均一に混合して微細に粉砕すれば、有効成分 1 0 %の粉剤を得る。 実施例 3 0 粒剤 If the above are uniformly mixed and finely pulverized, a powder containing 10% of the active ingredient is obtained. Example 30 Granules
本発明化合物 5部 5 parts of the compound of the present invention
クレー 7 3部 Clay 7 3 parts
ベントナイト 2 0部 Bentonite 20 parts
ジォクチルスルホサクシネートナトリウム塩 1部 Dioctyl sulfosuccinate sodium salt 1 part
リン酸ナトリウム 1部 1 part sodium phosphate
以上をよく粉碎混合し、水を加えてよく練り合せた後、 立乾燥して有効成分 5 %の粒剤を得る。 The above is well ground and mixed, water is added and the mixture is kneaded well.
実施例 3 1 懸濁剤 Example 3 1 Suspension
本発明化合物 1 0部 Compound of the present invention 10 parts
リダニンスルホン酸ナトリウム 4部 Sodium Ridanine Sulfonate 4 parts
ドデシルベンゼンスルホン酸ナトリウム 1部 Sodium dodecylbenzenesulfonate 1 part
キサンタンガム 0. 2部 Xanthan gum 0.2 parts
水 8 4. 8部 Water 84.8 parts
以上を混合し、膝が 1ミクロン以下になるまで湿式粉碎すれば、 有効成分 10 %の懸濁剤を得る。 The above mixture is mixed and wet-milled until the knee is less than 1 micron to obtain a 10% active ingredient suspension.
なお、本発明化合物は単独でも十分有効であることは言うまでもないが、 効力 が不十分もしくは弱い病害又は有害昆虫、 ダニに対しては各種の殺菌剤や殺虫 · 殺ダニ剤の 1種又は 2種以上と混合して使用することも出来る。 It goes without saying that the compound of the present invention is sufficiently effective alone, but it is one or two of various fungicides and insecticides and acaricides against inadequate or weak diseases or harmful insects and mites. It can be used in combination with the above.
本発明化合物と混合して使用出来る殺菌剤、殺虫剤、殺ダニ剤、植物生長調節 剤の代表例を以下に示す。 Representative examples of fungicides, insecticides, acaricides, and plant growth regulators that can be used by mixing with the compound of the present invention are shown below.
〔殺菌剤〕 キヤブタン、 フオルぺッ ト、 チウラム、 ジネブ、 マンネブ、 マンコゼブ、 プロ ビネブ、 ポリカーバメート、 クロロタロニル、 キン卜一ゼン、 キヤプタホル、 ィ プロジオン、 プロサイミ ドン、 ビンクロゾリン、 フルォロイミ ド、 サイモキサニ ル、 メプロニル、 フルトラニル、 ペンシクロン、 ォキシカルボキシン、 ホセチル アルミニウム、 プロパモカーブ、 トリアジメホン、 卜リアジメノール、 プロピコ ナゾール、 ジクロブトラゾール、 ビテルタノール、 へキサコナゾ一ル、 マイクロ ブタニル、 フルシラゾ一ル、 エタコナゾール、 フルオトリマゾ一ル、 フルトリア フェン、 ペンコナゾール、 ジニコナゾ一ル、 サイプロコナゾール、 フエナリモー ル、 トリフルミゾール、 プロクロラズ、 ィマザリル、 ぺフラゾエート、 トリデモ ルフ、 フヱンプロピモルフ、 卜リホリン、 ピリフヱノックス、 ァニラジン、 ポリオキシン、 メタラキシル、 ォキサジキシル、 フララキシル、 イソプロチオラ ン、 プロべナゾール、 ピロール二トリン、 ブラストサイジン S、 カスガマイシン、 バリダマイシン、 硫酸ジヒドロストレプトマイシン、 べノミル、 カルベンダジム、 チォファネートメチル、 ヒメキサゾール、 塩基性塩化銅; 塩基性硫酸銅、 フェン チンアセテート、 水酸ィ匕トリフヱニル錫、 ジエトフェンカルプ、 メタスルホカル ブ、 キノメチオナート、 ピナパクリル、 レシチン、 重曹、 ジチアノン、 ジノカツ プ、 フエナミノスルフ、 ジクロメジン、 グァザチン、 ドジン、 I B P、 エディフ ェンホス、 メパニピリム、 フヱリムゾン、 トリクラミ ド、 メタスルホカルプ'、 フ ルアジナム、 エトキノラック、 ジメ 卜モルフ、 ピロキロン、 テク口フタラム、 フ サライ ド。 〔Fungicide〕 Kyabtan, Format, Thiuram, Zineb, Maneb, Mancozeb, Provineb, Polycarbamate, Chlorothalonil, Kind Isen, Captahor, Hyperprodion, Procymidone, Vinclozolin, Fluoromid, Thymoxanil, Mepronil, Flutronyl, Flutranil Oxycarboxine, fosetyl aluminum, propamocarb, triadimefon, triadimenol, propiconazole, diclobutrazole, bitertanol, hexaconazole, microbutanyl, flusilazol, etaconazole, fluotrimazole, flutrifen, penconazole, diniconazo , Cyproconazole, fenarimol, triflumizole, prochloraz, imazalil, perfrazoe , Tridemolf, phenpropimorph, trifolin, pyrifenox, anilazine, polyoxin, metalaxyl, oxadixyl, furalaxyl, isoprothiolane, probenazole, pyrrolnitrin, blasticidin S, kasugamycin, validamycin, and dihydromycin dihydrostomycin sulfate Benomyl, carbendazim, thiophanate methyl, himexazole, basic copper chloride; basic copper sulfate, fentin acetate, triphenyltin hydroxide, dietofencarp, metasulfocarb, quinomethionate, pinapacryl, lecithin, baking soda, dithianon, Zinocap, phenaminosulf, diclomedine, guazatine, dozine, IBP, edifenfoss, mepanipyrim, furimzone, triclami , Metasulfocarp ', Fluazinam, Etoquinolac, Dimethomorph, Pyroquilon, Tekuguchi Phtharam, Fusalide.
〔殺虫 ·殺ダニ剤〕 (Insecticides and acaricides)
クロルべンジレート、 クロルプロピレート、 プロクロノール、 フヱニソブロモ レート、 ジコホル、 ジノブトン、 クロルフエナミジン、 アミ トラズ、 B P P S、 P P P S、 ベンゾメート、 へキシチアゾクス、 酸化フェンブタスズ、 ポリナクチ ン、 チォキノックス、 C P C B S、 テトラジホン、 イソキサチオン、 アベルメク チン、 多硫化石灰、 クロフヱンテジン、 フルべンズミン、 フルフエノクスロン、 B C P E、 シへキサチン、 ピリダベン、 フェンピロキシメート、 フヱンチオン、 フエニトロチオン、 ダイアジノン、 クロルピリホス、 E S P、 バミ ドチオン、 フ ェントェ一ト、 ジメ 卜エート、 ホルモチオン、 マラチオン、 ジプテレックス、 チ オメ トン、 ホスメット、 メナゾン、 ジクロルボス、 ァセフェート、 E P B P、 ジ ァリホーゾレ、 メチノレハ。ラチオン、 ォキシジメ トンメチノレ、 ェチオン、 ピラクロホ ス'、 モノクロトホス、 メゾミルモノクロ卜ホス、 アルディカーブ、 プロボキシュ —ル、 B PMC、 MTMC、 ナック、 カルタップ、 カルボスルファン、 ベンフラ カルプ、 ピリミカーブ、 ェチォフェンカルプ、 フエノキシカルプ、 パーメスリン、 サイパーメスリン、 デカメスリン、 フェンバレレート、 フェンプロパスリン、 ピ レトリン、 アレスリン、 テトラメスリン、 レスメスリン、 ジメスリン、 プロパス リン、 ビフェンスリン、 プロスリン、 フノレバ'リネート、 シフルスリン、 シハロス リン、 フルシリネート、 エトフェンプロックス、 シクロプロトリン、 トラ口メス リン、 シラネオファン、 ジフルべンズロン、 クロルフルァズ口ン、 卜リフルムロ ン、 テフルべンズロン、 ブプロフエジン、機械油。 Chlorbenzylate, chlorpropylate, proclonol, phenylisobromolate, dichophor, dinobutone, chlorphenamide, amitraz, BPPS, PPPS, benzomate, hexthiazox, fenbutatin oxide, polynacin, thioquinox, CPCBS, tetraxion, tetraxion Avermectin, lime polysulfide, cloventine, fluvensmin, flufenoxuron, BCPE, sihexatin, pyridaben, fenpyroximate, pentione, Phuenitrothion, Diazinon, Chlorpyrifos, ESP, Bamidothion, Fenthet, Dimethate, Formothion, Malathion, Dipterex, Thiometon, Hosmet, Menazon, Dichlorvos, Acephate, EPBP, Giarihoresole, Lathion, Oxidime Tonmetinore, Etion, Pyraclofos', Monocrotophos, Mezomil Monocrotophos, Aldicarb, Proboxir, B PMC, MTMC, Nack, Cartap, Carbosulfan, Benfracalp, Pirimicarb, Etioffenkarp, Phenoxycarp, permethrin, cypermethrin, decamethrin, fenvalerate, fenpropasulin, pyrethrin, allesulin, tetramethrin, resmethrin, dimethrin, propasulin, bifenthrin, prothrin, funolev'linate, cyfluthrin, cyhalosulin, fluprolinate, cycloproxine, etoprofen Trin, Tiger Mouth Lin, Silaneophan, Difluvenzuron, Chlorfluazin, Triflumuron, Teff Rubenslon, Buprofezin, Machine oil.
〔植物生長調節剤〕 (Plant growth regulator)
ジべレリン類(例えばジべレリン A3 、 ジべレリン A4 、 ジべレリン A7 ) I AA、 NAA。 Gibberellins (eg Gibberellin A 3 , Gibberellin A 4 , Gibberellin A 7 ) I AA, NAA.
産社の利用可能性: Availability of industrial companies:
次に、本発明化合物が各種植物病害防除剤の鶴成分として有用であることを 試験例で示す。防除効果は、調査時の供試植物の発病状態、 すなわち葉、茎等に 出現する病斑ゃ菌そうの生育の を肉眼観察し、 菌そう、 病斑が全く認められ なければ「5」、無処理区に比べ 1 0 %程度認めれば「4」、 2 5 %¾¾認めれ ば「 3 J、 5 0 %程度認めれば「 2」、 7 5 %程度認めれば 「 1 J 、無処理区の 発病状態と差異がなければ「0」 として、 0〜5の 6段階に f ffiし、 0、 1、 2、 3、 4、 5で示す。 Next, Test Examples show that the compound of the present invention is useful as a crane component of various plant disease controlling agents. The control effect was evaluated by visually observing the diseased state of the test plant at the time of the survey, i.e., the appearance of the lesions on the leaves, stems, etc. Compared to untreated plots, 4% if recognized about 10%, 25%; 3J if recognized; 2% if about 50% recognized; 1J if 75% recognized, If there is no difference from the state, it is set to “0” and the efficiency is evaluated in six stages from 0 to 5, and is indicated by 0, 1, 2, 3, 4, and 5.
試験例 1 コムギぅどんこ病防除試験(予防試験) Test Example 1 Wheat powdery mildew control test (prevention test)
素焼きポッ卜で栽培したコムギ幼苗(品種 「農林 6 1号 J 1 . 0〜; L . 2葉期) に本発明化合物の水和剤の所定濃度の薬液を散布し、葉を風乾させた後、 コムギ うどんこ病菌■ (E r y s i p h e g r ami n i s f . s p. t r i t i c i ) の分生胞子を振り払い接種し、 22 25 °Cの温室で 7日間生育させ、 防除 果を調査した。 その結果を第 4表に示す。 After spraying a predetermined concentration of a wettable powder of the compound of the present invention on wheat seedlings (cultivar “Norin 61 J 1.0-L. 2 leaf stage”) grown in unglazed pots and air-drying the leaves , Wheat The conidiospores of the powdery mildew fungus (Erysiphegraminisf.sp.tritici) were shaken off and inoculated, grown for 7 days in a greenhouse at 2225 ° C, and the control effect was investigated. Table 4 shows the results.
4 Four
* 1 : sulfur, 水和硫黄了 5%水和剤 試験例 2 キユウリうどんこ病防除試験 * 1: sulfur, sulfur hydrate 5% wettable powder Test Example 2 Test for Control of Powdery Mildew
約 3週間温室でボット栽培したキユウリ (品種「相模半白 )苗に、本発明化 合物の水和剤の所定濃度の薬液を十分量散布し、風乾させたのち、 キユウリうど んこ病菌(Sphae ro the _5_ f u 1 i g i ne a、薬剤に感受性な菌、 以 T¾M感性菌およびエルゴステ口ール生合成阻害型の殺菌剤に感受性が低下し た菌、以下感受性低下菌) の分生胞子懸濁液を噴霧接種した。 これを 23〜25 での恒温室におき、 菌接種 10日後に発病状態を調査した。 その結果を第 5表に 示す。 After spraying a sufficient amount of a solution of the compound of the present invention with a predetermined concentration of a wettable powder of a compound of the present invention on a cucumber seedling (variety “Sagamihanjiro”) cultivated in a greenhouse for about 3 weeks and air-drying, Sphae ro the _5_ fu 1 igi ne a, a conidia of a drug-sensitive bacterium, a T¾M-sensitive bacterium and a bacterium with reduced susceptibility to a bactericide that inhibits ergostate biosynthesis; The suspension was spray-inoculated, placed in a constant temperature room at 23 to 25, and examined for disease status 10 days after the inoculation of the bacteria, and the results are shown in Table 5.
第 5 表 有効成分濃度 防 除 効 果 Table 5 Concentration of active ingredient control effect
化合物番号 - 宝口 Compound Number-Takaguchi
(p pm) 薬剤感性菌 感受性低下菌 (p pm) Drug-sensitive bacteria Sensitivity-reducing bacteria
1-1 200 4 4 な し 1-1 200 4 4 None
-2 〃 5 5 -2 〃 5 5
-3 5 5 〃 -3 5 5 〃
-4 5 - 5 -4 5-5
一 8 5 5 One 8 5 5
-20 5 5 -20 5 5
-22 〃 5 5 -22 〃 5 5
-25 4 4 -25 4 4
一 26 〃 5 5 One 26 〃 5 5
1-5 5 5 1-5 5 5
一 6 ff 4 4 One 6 ff 4 4
-8 〃 5 5 〃 -8 〃 5 5 〃
-22 4 4 -22 4 4
-24 〃 4 4 (つづき) -24 〃 4 4 (Continued)
* 1 : sulfur, 水和硫黄 75%水和剤 * 1: sulfur, 75% wettable powder
* 2 : triadimefon 25%水和剤 試験例 3 ブドウべと病防除試験 * 2: Triadimefon 25% wettable powder Test example 3 Grape downy mildew control test
露地植えブドウ (品種 「甲斐路」 , 3年生) の葉を切りとり、 直径 3 Ommの 円盤に打ちぬいたものを、 本発明化合物の水和剤の所定濃度の薬液にうかべ、 ブ ドウべと病菌 (P l a sipop a r a v i t i c o l a) の遊走子のうの懸濁 液を噴霧接種し、 照明下、 20°C、 湿室に保ち、接種 10日後に発病の状況を調 査した。 その結果を第 6表に示す。 第 6 表 Leaves of open-grown grapes (variety "Kaiji", 3rd grade) cut out and punched into a 3 Omm-diameter disc are exposed to a chemical solution of a predetermined concentration of a wettable powder of the compound of the present invention. A suspension of zoospores of (P la sipop araviticola) was sprayed and inoculated, kept in a humidified room at 20 ° C under illumination, and the disease status was examined 10 days after the inoculation. Table 6 shows the results. Table 6
* 3 マンゼブ 75%水和剤 試験例 4 リンゴ黒星病防除試験(予防試験) * 3 Manzeb 75% wettable powder Test example 4 Apple scab control test (prevention test)
素焼きポッ卜で栽培したリンゴ幼苗(品種「国光」 、 3〜4葉期) に、 本発明 化合物の水和剤の所定濃度の薬液を散布し風乾させた後、 リンゴ黒星病菌 (Ve_ n t_u r i a i na e qua 1 i s)の分生胞子を接種し、照明下(明 ·暗く りかえし)、 20°C、 高 ' の室内に 2週間保持した後、 防除効果を調査した。 その結果を第7表に示す。 After spraying a predetermined concentration of a wettable powder of the compound of the present invention and air-drying it onto apple seedlings (variety “Kunimitsu”, 3-4 leaf stage) cultivated in unglazed pots, apple scab (Ve_nt_u riai) nae qua 1 is) and inoculated in a room at 20 ° C under high light for 2 weeks under light (bright and dark), and the control effect was investigated. Table 7 shows the results.
第 7 表 Table 7
*4 キヤブタン 80%7jc和剤 * 4 Kyabtan 80% 7jc
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3/303771 | 1991-10-24 | ||
| JP30377191 | 1991-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1993008167A1 true WO1993008167A1 (en) | 1993-04-29 |
Family
ID=17925092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP1992/001384 Ceased WO1993008167A1 (en) | 1991-10-24 | 1992-10-23 | Novel heterocyclic derivative and agrohorticultural bactericide containing same |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO1993008167A1 (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003088963A1 (en) * | 2002-04-16 | 2003-10-30 | Ortho-Mcneil Pharmaceutical, Inc. | 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases |
| WO2005042500A1 (en) * | 2003-10-03 | 2005-05-12 | Ortho-Mcneil Pharmaceutical, Inc. | Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
| US6903109B2 (en) | 2001-04-18 | 2005-06-07 | Ortho-Muniel Pharmaceutical, Inc. | Arylindenopyridines and related therapeutic and prophylactic methods |
| US7122544B2 (en) | 2000-12-06 | 2006-10-17 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| US7129242B2 (en) | 2000-12-06 | 2006-10-31 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
| US7345052B2 (en) | 2002-04-16 | 2008-03-18 | Ortho-Mcneil Pharmaceutical, Inc. | Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| US7351729B2 (en) | 2002-03-08 | 2008-04-01 | Signal Pharmaceuticals, Llc | JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers |
| JP2016502529A (en) * | 2012-11-30 | 2016-01-28 | エルジー・ケム・リミテッド | Novel compound and organic electronic device using the same |
| EP4039094A1 (en) * | 2021-02-03 | 2022-08-10 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel antifungal compounds |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4717725A (en) * | 1984-04-11 | 1988-01-05 | Alcon Laboratories, Inc. | Ophthalmic wound healing with aldose reductase inhibitors |
-
1992
- 1992-10-23 WO PCT/JP1992/001384 patent/WO1993008167A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4717725A (en) * | 1984-04-11 | 1988-01-05 | Alcon Laboratories, Inc. | Ophthalmic wound healing with aldose reductase inhibitors |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7129242B2 (en) | 2000-12-06 | 2006-10-31 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
| US7442699B2 (en) | 2000-12-06 | 2008-10-28 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| US7122544B2 (en) | 2000-12-06 | 2006-10-17 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| US6903109B2 (en) | 2001-04-18 | 2005-06-07 | Ortho-Muniel Pharmaceutical, Inc. | Arylindenopyridines and related therapeutic and prophylactic methods |
| US6958328B2 (en) | 2001-04-18 | 2005-10-25 | Ortho-Mcneil Pharmaceutical, Inc | Arylindenopyridines and related therapeutic and prophylactic methods |
| US7351729B2 (en) | 2002-03-08 | 2008-04-01 | Signal Pharmaceuticals, Llc | JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers |
| US7345052B2 (en) | 2002-04-16 | 2008-03-18 | Ortho-Mcneil Pharmaceutical, Inc. | Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| WO2003088963A1 (en) * | 2002-04-16 | 2003-10-30 | Ortho-Mcneil Pharmaceutical, Inc. | 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases |
| US7468373B2 (en) | 2002-04-16 | 2008-12-23 | Ortho-Mcneil Pharmaceutical, Inc. | Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| US7754730B2 (en) | 2002-04-16 | 2010-07-13 | Ortho-Mcneil Pharmaceutical, Inc. | Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| JP2007521243A (en) * | 2003-10-03 | 2007-08-02 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | Arylindenopyridines and arylindenopyrimidines and their use as adenosine A2a receptor antagonists |
| WO2005042500A1 (en) * | 2003-10-03 | 2005-05-12 | Ortho-Mcneil Pharmaceutical, Inc. | Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
| JP2016502529A (en) * | 2012-11-30 | 2016-01-28 | エルジー・ケム・リミテッド | Novel compound and organic electronic device using the same |
| US10790453B2 (en) | 2012-11-30 | 2020-09-29 | Lg Chem, Ltd. | Compounds and organic electronic device using the same |
| EP4039094A1 (en) * | 2021-02-03 | 2022-08-10 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel antifungal compounds |
| WO2022167503A1 (en) * | 2021-02-03 | 2022-08-11 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel antifungal compounds |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69023171T2 (en) | Condensed heterocyclic compounds, their production and use. | |
| JP3934164B2 (en) | 4-Quinolinol derivatives and agricultural and horticultural fungicides containing this as an active ingredient | |
| JPS63216848A (en) | Propenoic acid derivative, manufacture and fungicidal composition | |
| DD291997A5 (en) | PROCESS FOR THE PREPARATION OF PROPENE AEDEED DERIVATIVES | |
| JPS62294657A (en) | Acrylic acid ester derivative, manufacture and agricultural drug composition | |
| JPH0184A (en) | Picolinate derivatives and herbicides | |
| HU201726B (en) | Process for producing propenecarbpxylic acid esters and fungicides and plant growth regulators comprising propenecarboxylic acid esters as active ingredient | |
| JPS62258344A (en) | Acrylic acid derivatives, manufacture and fungicidal, insecticidal or plant growth regulator | |
| JPWO1998055460A1 (en) | 4-Quinolinol derivative and agricultural and horticultural fungicide containing same as active ingredient | |
| WO1993007138A1 (en) | Pyrazole derivative and agrohorticultural bactericide containing same | |
| WO1993008167A1 (en) | Novel heterocyclic derivative and agrohorticultural bactericide containing same | |
| JPH04224580A (en) | Pyrimidine derivative, production thereof and agricultural and horticultural fungicide | |
| JPH0331269A (en) | Propane acid drivative, its manufacture, sterilizer compound and sterilization | |
| EP0422456B1 (en) | Pyridine derivatives and their use in combating unwanted plant growth | |
| CN118666857B (en) | A quinoline compound and its application in agricultural fungicide | |
| WO1996017841A1 (en) | Pyridylpyrrole compounds, process for production, and agrohorticultural bactericide | |
| WO2002064566A1 (en) | Oxime o-ether compounds and fungicides for agricultural and horticultural use | |
| DE3602148A1 (en) | HETEROCYCLIC COMPOUNDS | |
| EP0361161B1 (en) | Naphthindazole-4,9-chinones and their use in combating unwanted plant growth | |
| JP2517992B2 (en) | Pyridylpyrimidine derivative and plant disease controlling agent containing the same | |
| JPS63287750A (en) | Propenoic acid compound, manufacture and fungicidal composition | |
| JPH03220178A (en) | Bactericidal compound, its preparation and bactericidal composition containing same | |
| EP0655444A1 (en) | Oxazoline derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same | |
| JP3054977B2 (en) | Fungicidal furanone derivative | |
| JP3066536B2 (en) | Condensed heterocyclic derivatives and herbicides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE |
|
| 122 | Ep: pct application non-entry in european phase |